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ABSTRACT

DOUGLAS K. BREES.

Heterogeneous Macromolecular Composition of Renal

Basement Membranes in Health, Diabetes and Glomerulonephritis. (Under the direction
of JAMES C. WILLIAMS, JR.)

Although basement membranes are ubiquitous structures throughout the body,
basement membranes have distinct compositions that are specific to their location. This
basement membrane heterogeneity may, in part, reflect functional differences among
various basement membranes. We examined basement membrane heterogeneity in
normal, healthy mouse kidneys to assess the similarities and differences between
glomerular and tubular basement membrane composition. It was demonstrated that
mouse glomerular and tubular basement membrane share similar compositions but differ
with respect to specific amounts of some components.
In diabetes mellitus and passive Heymann nephritis (PHN) , damage to the
glomerular barrier occurs and is accompanied by an increase in penneability to proteins
the size of albumin and larger: Presumably, the biochemical nature of the filter is not
maintained. The acute effects of streptozotocin diabetes and PHN on the macromolecular
composition of rat GBM was investigated to determine if changes in composition
correlated with proteinuria in these two models of kidney disease. Diabetes and PHN
were shown to have differential effects on GBM composition during the establishment of
proteinuria. Diabetes affected the GBM macromolecular composition; a significant
reduction in anionic charge content correlated with significant proteinuria and significant
increases in both laminin and fibronectin that occurred during the period immediately
following proteinuria. However, PHN had no effect on the GBM macromolecular
composition despite overt proteinuria after five days.

VI

These results suggest that the stimuli that lead to changes in GBM composition in
diabetes are likely related to those which result in proteinuria; however, there appears to
be no relationship between the GBM composition and overt proteinuria in PHN, or the
mechanisms for the induction of proteinuria between diabetes and PHN.

I. INTRODUCTION

2

Basement membranes are a specialized form of extracellular matrix that underlie all
epithelia, and surround adipocytes, peripheral nerves, and muscle fibers. Studies utilizing
tumors that synthesize large amounts of basement membrane-like matrices, such as the
mouse Englebreth-Holm-Swann (EHS) sarcoma, have been useful in determining the
macromolecular composition of basement membranes;

a number of these

macromolecules, including type IV collagen [1], laminin [2], fibronectin [3], entactin [4],
and heparan sulfate proteoglycan [5] have been characterized.

Along with these

macromolecules, it has been suggested based on electrophoretic examination that
basement membranes contain many more proteins [6]. The structural architecture of
basement membranes is composed of a backbone of type IV collagen to which attach
laminin, fibronectin, entactin, and heparan sulfate proteoglycan resulting in a highly
compact three-dimensional meshwork [7].
Basement membranes have been ascribed several functions: they help maintain
tissue architecture by providing a sheet-like support to which cells attach, and influence
cell growth and differentiation [8].

Basement membranes also function to

compartmentalize tissues, orient and polarize epithelia, provide substrates for

wo~nd

healing and tissue regeneration, and restrict the passage of macromolecules [9]. The
function as a filter is best described in the kidney in which the glomerular basement
membrane provides the only continuous barrier between the blood and the urinary space,
and selectively prevents large macromolecules from leaving the blood space. This
function is believed to be related directly to the specific macromolecular composition and
architecture of the glomerular basement membrane [10].
The understanding of the macromolecular composition and structural architecture of
the glomerular basement membrane during normal conditions of health is of paramount
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importance as alterations in composition have been shown to be intimately associated
with various pathological states.

The characteristic feature of altered basement

membrane morphology in renal dis~ase is an increase in glomerular basement membrane
width and expansion of mesangial matrix [11]. The functional abnonnality associated
with this alteration is impairment of selective filtering with resultant proteinuria [11].
The appearance of proteinuria, indicates loss of nonnal kidney penneability. It has
generally been assumed that the morphological and functional' alterations of basement
membranes in human and experimental disease must be accompanied by associated
changes in their chemical composition and structure. However, compositional analyses
of human GBM and animal GBM in experimental disease have produced incomplete and
contradictory data.
Insulin-dependent diabetes mellitus, a metabolically induced disease, is
characterized by progressive GBM thickening and proteinuria in later stages. There is
evidence that diabetic glomerular basement membrane undergoes distinct compositional
changes [12];

however, specific macromolecular changes have yet to be directly

correlated with the onset of the functional alterations.
Passive Heymann nephritis, an immunologically-induced animal model of human
membranous glomerulonephritis, is characterized by progressive GBM thickening and
rapid onset of severe proteinuria [13]. However, very little data is available on alterations
of GBM components in this disease. Although diabetes mellitus and passive Heymann
nephritis share thickened GBM and proteinuria, the rates of induction and the degrees of
proteinuria are extremely different.

Furthermore, changes in the macromolecular

composition of glomerular basement membrane have been implicated in the pathogenesis
of proteinuria in both diseases; however, the specific mechanisms are unknown [13,14].
Thus, the precise localizations and amounts of these components within the basement
membrane warrant extensive study_
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Most studies of basement membrane composition have involved electron
microscopy in conjunction with immunostaining. These studies are useful in detennining
the localization of basement membrane components; however, these techniques do not
permit determination of absolute concentrations. of various components of basement
membranes.

The assessment of known as well as unknown components requires

solubilization of the basement membrane. This structure has been shown to be highly
cross-linked and relatively insoluble by conventional solubilization techniques [8]. Thus,
the inclusions of strong denaturants and reducing agents are required to solubilize the
basement membrane components [15].

Mohan and Spiro [15] have developed a

technique that sequentially solubilizes the basement membrane components: The frrst
step involves sonicating the membrane in the presence of guanidine-Hel, a denaturant, to
solubilize attached proteoglycans and various glycoproteins.

The second step

incorporates dithiothreitol, a reducing agent, with the guanidine-Hel and sonication to
solubilize any remaining glycoproteins leaving an enriched type IV collagen pellet. And
finally SDS with sonication solubilizes this collagenous material to a limited extent. This
sequential extraction procedure conveniently fractionates the complex and numerous
components of the basement membrane. Subsequently, both known and unknown
components in these fractions can be qualitatively and quantitatively evaluated using
standard electrophoretic and immunoblotting methods and quantitation of specific
components using solid-phase immunoassays.
The overall goal as outlined in this dissertation was to determine the compositional
heterogeneity in healthy isolated kidney basement membrane and then to assess, using
two animal models whereby similar functional changes have occurred in the kidney
filtration barrier, if changes in isolated GBM composition correlate with observed
functional changes in diseased states. The frrst part of this goal involved the isolation of
glomerular and tubular basement membranes from the same kidneys of healthy mice and
subsequently to:
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1. Qualitatively assess differences in solubilized basement membrane
components between the glomerular and tubular basement membranes
using SDS-PAGE and imrnunoblotting techniques.

2. Quantitatively assess differences in the amounts of extracted laminin

and fibronectin between the glomerular and tubular basement membranes
using inhibitory ELISA.

To assess the second part of the goal, the following hypothesis was tested: Changes

in the macromolecular composition of isolated GBM correlate with proteinuria in both
streptozotocin-induced diabetes and immunologically-induced passive Heymann
nephritis (PHN) in rats. To test this hypothesis, the following specific objectives were
proposed:

1. Qualitatively assess differences in the macromolecular compositions
between the GBM in diabetes and PHN by gel-electrophoresis and
immunoblotting techniques.

2. Quantitatively assess differences in type IV collagen, laminin,
fibronectin and entactin content between the GBMs in diabetes and PHN
using inhibitory ELISA.

3. Quantitatively assess the anionic charge between the GBMs of rats with
diabetes and PHN.

4. Qualitatively assess the purity of the isolated GBM to detennine if
loss of basement membrane components occurred during isolation
procedures.
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Studies of insulin-dependent diabetes mellitus and passive Heymann nephritis thus
far have failed to evaluate changes in GBM composition in the acute phases of these
disease models, specifically looking at the pathogenesis of these diseases. Thus, the
novel feature of the study summarized in this dissertation is the assessment of GBM
composition with the pathogenesis of two animal models of kidney disease that share a
similar functional change.

n

Background
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A

MACROMOLECULAR COMPOSITION OF BASEMENT MEMBRANES.

Type IV Collagen
Basement membranes are formed by a fine network of cords that are woven
together and associate with molecules such as

laminin~

entactin!nidogen and heparan

sulfate proteoglycan [7]. This network is made up of a type IV collagen skeleton [16].
Existence of two type IV collagen chains~ al(N) and a2(IV), have been known for some
time and these are referred to as the classical chains [17]. Recent evidence for the
presence of three additional chains in some basement membranes has been obtained
through partial characterization of two chains bearing the epitopes responsible for
Goodpasture's syndrome, an autoimmune disease affecting particularly the GBM, and
through the cloning of a cDNA encoding another basement membrane chain [18-21].
These three novel chains have been given names a3(IV), a4(IV) and a5(IV). The
a5(N) chain recently was shown to be defective in Alport's syndrome, a heritable

condition resulting in severe kidney dysfunction [22].
The monomeric or protomeric structure of type IV collagen is composed of the
classical collagen chains [a1(1V)2a2(N)] and possesses three distinct domains: a small
helical N-terminal domain (7S), C-terminal globular domain (NC-1) and the central
major helical domain [23] (Fig. II.1). As found in fibrillar collagens (types I, II, and III),
the major helical and 7S domains have over the greater part of their length Gly-x-y
repeats. In contrast to these fibrillar

collagens~

which are rigid inflexible rods, type IV

collagen has several nonhelical interruptions throughout the major helical domain [24].
These interruptions are believed to impart the flexibility observed in this collagen
molecule [24].

Type IV collagen monomers can assemble to form stable three

dimensional structures using three types of interactions [25]. First, disulfide bonds can
fonn between the NC-l domains of two separate monomers. Second, the 7S domain of
one monomer can bind to three other monomers in an antiparallel overlapping association
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thus forming a tetrameric structure. This arrangement is stabilized by disulfide bonds and
hydrophobic interactions. Finally, collagen dimers associate through lateral interactions
fonning a polygonal network [25].
One of the fIrst roles assigned to type IV collagen was the association of monomers
fonning large supramolecular aggregates thus generating supportive structures [8].
Recently, this molecule has been shown to bind to laminin, entactin/nidogen,
proteoglycans, and various cells [25]. The biological activity of type IV collagen has
been studied in several environments. Sympathetic neurons plated on type IV collagen
exhibited neurite outgrowth, a characteristic feature of neuronal growth. Further study
revealed that the NC-l domain was the epitope for this neuronal activity [26]. Another
area of intensive research is in the f'mding that several tumor cell lines attach directly to
type N collagen, presumably an important mediator in cancer cell metastasis [27].

Laminin
Laminin was initially isolated and characterized from the murine EHS tumor [2].
Since then, laminin has been isolated in naturally occurring basement membranes and is
currently recognized as being a family of large, multidomain, isomeric glycoproteins and
because of this the prototypic EHS laminin molecule is now referred to as "classical"
laminin [25].

Classicallaminin is composed of three genetically distinct polypeptide

chains designated as Ae, Ble and B2e.

These three chains assemble to form an

asymmetric cross shape with three short arms and one long arm (Fig. IT.I) [28]. Each of
the two short arms contains a central and terminal globular domain while the long arm
contains two central and a terminal globular domain at each end [28]. From limited
proteolysis of classicallaminin, several fragments or domains with specific biological
activities have been discovered [8]. The ends of the short arms bind to regions of type IV
collagen and the long ann binds to heparan sulfate proteoglycan [8]. The pepsin derived
fragment, PI, contains segments of the short arms near the center of the cross. PI
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contains two sequences of amino acids shown to be involved in cell binding with laminin,
YIGSR and RGD, and dermes one of the two described cell binding domains [29]. The

other cell binding domain is present in the elastase derived fragment, E8, which
corresponds to a segment of the long ann and contains portions of all three chains. In
addition, E8 also promotes neurite outgrowth, and may be responsible for maintaining
cell polarity [30].
With monoclonal antibodies and cDNA cloning techniques, isofonns of laminin
were discovered. Original studies revealed the non-synchronous expression of the Ae,
Ble, and B2e chains during early development. Ble and B2e chains were identified at
the four to eight cell stage, while the Ae chain was not detectable until the sixteen cell
stage of mouse embryos [31]. Other studies revealed that laminin isolated from various
sources consisted of different structures: polypeptide chain substitution or lacking one of
the three chains. S-laminin was detected with monoclonal antibodies that selectively
stained synaptic basement membranes [32]. Cloning of S-laminin revealed extensive
homology with both mouse laminin Be chains; however, the homology to Ble is greater
than to B2e. Thus, S-laminin is now referred to as Bis [25]. Immunofluorescence
studies revealed the presence of S-laminin in glomerular but not tubular basement
membrane [32,33]. An isofonn of laminin A chain was discovered in extracts of human
placenta [34]. This new molecule, initially named merosin, has been shown by partial
sequence analysis to be homologous to the laminin Ae chain and thus is now referred to
as laminin Am chain [25].
Laminin can polymerize through terminal globular domains of all four anns of the
cross and the polymerization is Ca++ dependent. Apart from type IV collagen, laminin is
the only basement membrane component known to polymerize; this may be an important
function particularly in basement membranes lacking type IV collagen [35]. Yurchenco
et al recently revealed that this laminin self-association is necessary for the architectural
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maintenance of the collagen-free basement membrane of cultured. embryonic carcinoma

cells [36].

Fibronectin
Fibronectin is a glycoprotein that exists as two forms, either as a soluble plasma
fonn or as an insoluble cellular fonn [8]. While its presence has been observed in many
basement membranes, some authors propose that it is simply a molecule entrapped within
the membrane [37]. Most immunohistochemistry data suggest that fibronectin is a
component of basement membranes [9]. Fibronectin is a dimer of two similar or identical
chains that are linked at their C-termini by disulfide bonds (Fig. 11.1). Each chain is

defined by a number of functional domains. Some of these domains include binding sites
for cellular receptors, fibrin, DNA, collagen, and beparan sulfate [9]. The cellular and
plasma forms of fibronectin are almost identical, originating from the same gene;
however, alternative splicing of the transcript inserts two additional domains, E3A and
E3B, into the cellular fonn [8]. A central cell-binding domain or 75 Kd fragment exists
in both fonns of fibronectin and contains the sequence ROD, identified as the minimal
amino acid sequence recognized by a number of integrin receptors [38].
Fibronectin has been shown to play a role in cellular adhesion, either between cells
[39] or between cells and the extracellular matrix [40]; and the adhesion plaques

represent the anchorage of extracellular fibronectin to the intracellular microfllaments of
actin [41]. Recently it has been demonstrated that this interaction is mediated by the
integrin fibronectin receptor [42]. Fibronectin may playa role in the transmission of
signals from the basement membrane to cytoplasmic sources or even to the level of the
nucleus.
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EntactinlNidogen
Entactin and nidogen were isolated from two different mouse tissue sources and
thought to be different molecules; however, sequencing data demonstrated that the two
molecules were identical [43].

These molecules are currently referred to as

entactin/nidogen [25]. Entactin/nidogen is a sulfated. glycoprotein and has the shape of a
dumbbell, consisting of two globular domains connected by a short rod-like segment [35]
(Fig. 11.1). This molecule is broken down into three domains: Domain I is the Ntenninal globular domain, domain IT is the rod-like portion, and domain III is the Ctenninal globular domain. Domain IT has been shown to contain five consecutive
epidermal growth factor-like repeats (cysteine-rich repeats) [25].
Entactin/nidogen forms tight, noncovalent complexes with laminin.

These

complexes are a result of the globular domain In of entactin/nidogen binding to the inner
segment of one short ann of laminin Bl chain [35]. This complex fonnation imparts on
entactin/nidogen an increased protease resistance. This molecule has also been shown to
bind to type IV collagen. However, the binding of entactin/nidogen to type IV collagen is
not as strong as the binding forces with laminin [44]. This interaction has led to the
suggestion that entactin/nidogen may act as a major bridging protein [35]. Furthennore,
this molecule contains an ROD sequence and has been shown to support cell adhesion and
to bind calcium ions [45].

Proteoglycans
Proteoglycans are a class of macromolecules characterized by a protein core to
which glycosaminoglycans are coyalently bound. It is the type of glycosaminoglycan that
defmes the class of proteoglycan: keratan sulfate, dennatan sulfate, chondroitin sulfate
and heparan sulfate. Furthermore, the number of attached glycosaminoglycans and size of
protein cores can vary considerably for each class of proteoglycan, thus giving rise to
isofonns within each class. TIle glycosaminoglycans are long linear polymers composed
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of a repeating disaccharide sequence, usually a sulfate-substituted amino sugar and an
uronic acid.

Because of the sulfate groups on most of the sugar residues,

glycosaminoglycans are highly negatively charged [46].
Heparan sulfate is the most predominant glycosaminoglycan (85%) found in renal
basement membrane proteoglycans; however, small amounts of chondroitin sulfate (15%)
are also present [47]. Two forms have been isolated from the EHS tumor, a low density
fonn with a large protein core and a high density form with a small protein core (Fig. 11.1).
The low density form consist of a 500 Kd protein core to which three heparan sulfate
chains attach to one end [25]. The high density form has a small 18Kd core protein with
four heparan sulfate chains [25]. Similar, but not identical, heparan sulfate proteoglycans
have been isolated from GBM. These molecules are similar at the immunological level
but differ with respect to size of protein core and degree of sulfation. For example, a high
molecular weight fonn from bovine GBM was found to consist of a 200 Kd core protein
with four heparan sulfate chains attached to one end [48].
Heparan sulfate side chains can bind to laminin and type IV collagen, modulating
their capacity to self-associate [49]. Heparan sulfate proteoglycan-Iaminin interactions
resulted in an augmentation of laminin aggregate formation. Heparan sulfate proteoglycan
induced laminin complexes were more densely arranged than normal. Conversely,
heparan sulfate proteoglycan binding to type IV collagen resulted in the inhibition of
normal lateral associations of type IV collagen and subsequent network formation [50]. In
the GBM, heparan sulfate proteoglycans are thought to serve as the major chargepermselective barrier due to the anionic charge of the sulfated glycosaminoglycans [51].
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B

BASEMENT MEMBRANE STRUCTURAL AND FUNCTIONAL
RELATIONSHIPS.

Electron microscopy studies of the glomerular basement membrane reveal the
presence of three distinct layers: an electron-dense layer tenned the lamina densa, and
two electron-lucent layers the laminae rarae, opposing each side of the lamina densa [9]
y

(Fig. ll.2). Innumerable immunoelectron microscopy studies have been conducted on the
glomerular basement membrane and have suggested restricted localizations in the three
defined layers for the above-mentioned macromolecules. One group of investigators
argued that these layers were an artifact of fixation [52]. It was shown that when using
rapid-freezing with freeze-substitution a single homogeneous layer was revealed instead
of the three defined layers. Unfortunately, no immunostaining studies were done on this
freezed-flXed tissue to detennine if the macromolecular components were also distributed
homogeneously. Other studies have revealed that the mode and stringency of fIXation
affects the appearance and relative thicknesses of the three layers; however, the layers are
always present [7]. Nevertheless, support for the homogeneous basement membrane is
scarce and examination of the basement membrane using a chemical fixative with
subsequent transmission electron microscopy is the standard technique. High resolution
electron microscopy" studies have given rise to several proposed models of basement
membrane architecture.
The most accepted model thus far is one of Yurchenco and coworkers [24]. In this
model, the superstructure or backbone of basement membrane is a network of type IV
collagen upon which other components attach. As described earlier, type IV collagen can
associate through three processes to form this backbone: C-terminal dimerization, 7S
amino tenninal tetramerizations, and lateral associations. These three interactions are all
II

stabilized through covalent cross-links resulting in a three-dimensional meshwork.
Laminin polymers, formed through interactions between the ends of the short and long
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arms can then attach to the collagen meshwork directly or through entactinlnidogen
bridges. Heparan sulfate proteoglycan has been shown to form oligomers through core
protein interactions. The free ends of the heparan sulfate side chains can bind weakly to
the laminin long arm globular domain and type IV collagen [35]. The affinity of laminin

binding to heparan sulfate chains is influenced by the degree of sulfation., such that a
higher sulfate content of the heparan sulfate glycosaminoglycans results in stronger
binding to Iaminin [53]. From tissue culture studies, evidence for strong binding of
laminin with the core protein of beparan sulfate proteoglycan exists; however, this
protein-protein interaction has not been demonstrated in vivo [54]. In a high resolution
immunoelectron microscopy study of the GBM, Laurie et al demonstrated a network of 34 nm cords [7]. These cords were centered by type N collagen, surrounded by laminin,

fibronectin and heparan sulfate proteoglycan macromolecules. Although these results
support the Yurchenco model, it is important to point out two limitations of this model for
basement membrane architecture: 1) inability to explain the three layers observed in
chemically fixed basement membrane, and 2) the inability to match the small theoretical
pore size, of 9 run [24].
Basement membranes were originally thought only to provide an underlying support
for tissue, yet evidence now suggests that the number of functions defined for basement
membranes are continually increasing. Some of these functions are: compartmentalize
tissues, provide support to which cells can attach, influence cell shape, growth and
differentiation, and act as a molecular sieve. Compartmentalization and structural support
of tissue occurs throughout the human body. The basement membrane of the skin serves
to provide a resilient scaffold to which epithelial cells attach and also serves to segregate
the epidennis from the underlying dermis. Glomerular basement membrane serves to
maintain cell shape and orient cell polarity. In one study, when glomerular epithelial cells
were cultured and plated on collagen gel matrix, they attached, flattened out and secreted
basement membrane constituents from the basolateral surfaces [55]. When, these cells
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were treated with ammonium chloride, known to disrupt secretion in polarized cells,
secretion of the basement membrane components occurred on the apical surface as well
[55]. The attachment of cells to the basement membrane occurs through interactions with
transmembrane matrix-binding proteins on cell surfaces [25]. The best example of this
process are the integrin receptors for basement membrane components as described
earlier. For example, antibodies to the a6 integrin subunit (interacts with the E8 fragment
of laminin) inhibited the inductive formation of kidney epithelia in kidney organ cultures.
The importance of attachment of cells to the basement membrane was demonstrated [56].
During the process of nephron development, the interaction of cells with the basement
membrane is essential for the completion of conversion and morphogenic events [57]. In
studies of mouse nephrogenic mesenchyme, only small amounts of laminin B chain were
present in these undifferentiated cells. At the time of epithelial conversion of the
mesenchyme, the laminin A chain, type IV collagen and heparan sulfate proteoglycan
abruptly appeared [57].
Alterations in these components have been implicated in various renal diseases. For
example, in autosomal recessive polycystic kidney disease there is altered gene expression
of basement membrane components during kidney development [58]. Initially, alterations
in laminin B chains and type IV collagen mRNA from whole kidneys resulted in
abnormally low levels, whereas immunostaining for the proteins appeared normal.
Subsequently, the levels for these mRNAs were excessively high and immunostaining was
weakly

detectable~

Morphologically, the developing proximal tubules appeared dilated,

and the basement membrane was thickened.
The importance of the basement membrane acting as a perm-selective filter cannot
be emphasized enough in the kidney. The glomerulus filters the blood producing a

protein-free ultrafiltrate of the blood plasma [9]. This specialization depends on the
collective contribution of three components: the endothelium, glomerular basement
membrane, and the epithelium [59]. The size and charge selective capacity of the GBM
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has been determined from clearance studies of neutral and charged dextrans of various
sizes.

In one such study, size discrimination was demonstrated by the increasing

restriction to filtration with neutral dextrans of increasing molecular radius [60]. In
addition, charge discrimination was observed when negatively charge dextran sulfates
were restricted while positively charged DEAE (diethylaminoethyl) filtration was
increased. From these studies, the GBM was assigned a 66,000 Dalton molecular weight
cut-off, a pore size of 3.6 nm in diameter for filtration, and it was estimated that
macromolecules the size of albumin and larger were prevented from passage.
Alternatively, Schnitzer calculated the minimum effective "pore" radius to be 5.7 nm
based on collagen IV molecules having a 0.07 nm radius [61]. This reevaluation of the
theoretical "pore size" was performed using the fiber-matrix model, a more consistent
model in light of the architecture of basement membranes; however, this model only
reflects theoretical calculations and not what gets through. The presence of "pores" have
not been demonstrated in GBM.
The size selective nature of the OBM is believed to be imparted by the tbreedimensional meshwork composed of a type IV collagen backbone to which other
basement membrane constituents are attached [7].

The increased permeability to

positively charged macromolecules combined with the use of cationized probes
demonstrated that the GBM was negatively charged [60]. Rennke et al [62], demonstrated
that, whereas anionic ferritin did not penetrate, cationized ferritin penetrated to a great
extent into the GBM. Various stains, for example ruthenium red [63], were used to detect
anionic sites in the GBM and, in conjunction with enzymatic studies selectively degrading
the anionic constituents, the importance of sulfated glycosaminoglycans in glomerular
charge perm-selectivity was established [64,65].
It is generally understood that basement membranes are heterogeneous with respect
to composition as will be demonstrated in chapter three [66]. Perhaps differences in the
relative concentrations of individual constituents may result in different permeability
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properties in these basement membranes.

Thus, it is possible that differences in

permeability properties of various segments of the nephron may be influenced by
heterogeneous basement membranes underlying the tubular epithelium.

C

BASEMENT MEMBRANE ALTERATIONS IN DIABETES MELLITUS.

The remarkable specialization of the kidney as a macromolecular sieve is
undoubtedly due to the particular organization of the glomerular barrier, mainly the
fenestrated endothelial cells, the glomerular basement membrane and the epithelial cells
which generate the slit pores (Fig. ll.2). As mentioned above, the GBM is a highly
crossed-linked three-dimensional meshwork that imparts a size and charge selective
capacity to the OBM. In diabetes mellitus, loss of selective penneability with proteinuria
constitutes one of the major characteristics of diabetic nephropathy_ It is believed that
progressive accumulation of glomerular extracellular matrix, both glomerular basement
membrane and mesangial matrix, is an important aspect of the defect that leads to
proteinuria and ultimately to glomerular sclerosis with loss of functioning filtration units
[59]. It has been commonly assumed that these morphological and functional alterations
of the glomerular basement membrane in human and experimentally induced diabetes
must be accompanied by changes in their macromolecular composition and structure
[67].· A number of mechanisms have been proposed to explain the thickening of
glomerular basement membrane:

increased synthesis, decreased degradation and

removal, or an accelerated turnover of basement membrane synthesizing cells [67].
In general, two approaches have been used to study alterations of glomerular
basement membrane in diabetes: 1) compositional analysis of isolated GBM from
human or experimental animals and 2) biosynthesis of basement membrane by either
whole glomeruli, renal cortex, or cultured cells isolated from the glomerulus. Evidence
that the human GBM undergoes distinct compositional changes in diabetes was initially
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(1970) obtained from amino acid and carbohydrate analyses, which indicated that
constituents associated with collagen (hydroxyproline and hydroxylysine) were
significantly elevated while the level of glucouronic acid, a component of
glycosaminoglycans, was decreased [68]. Furthermore, analyses of whole glomeruli
demonstrated that the content of basement membrane material was substantially elevated
above the nonnal in diabetes [69]. In contrast, subsequent studies failed to confinn these
differences [70-72]. These studies indicated that the relative proportion of hydroxylated
amino acid residues increased, but not significantly, implying that synthesis of all
components was increased or that turnover was decreased. Thus, based on these studies,
whether statistically significant or not, it is generally believed that there is an increase in
the relative hydroxylated amino acid content in diabetic GBM over control, suggesting an
enrichment of the basement membrane by the collagen component.
Measured amounts of laminin, fibronectin and entactin in diabetic GBM have not
been clearly demonstrated. Shimomura and Spiro [12] showed a significant reduction in
the amount of laminin in human diabetic GBM, while in diabetic mice laminin was
increased [73]. In addition, mRNA levels for laminin Bl chain were significantly
increased in streptozotocin diabetic rats [74]. Amounts of fibronectin measured in human
diabetic GBM were unchanged [12]; however, cultured glomerular endothelial cells
exposed to high glucose concentrations resulted in increased expression of fibronectin
mRNA [75]. Amounts of GBM entactin have not been measured in human and
experimental models of diabetes.
The functional significance of these altered GBM components has not been
established. Furthennore, it has yet to be demonstrated that thickened GBM directly
correlates with changes in filtration. It has been suggested that compositional changes
lead to alterations in the interactions of the GBM constituents. Therefore, these
alterations may induce modifications in the three-dimensional architecture of the
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basement membrane and could be responsible for the loss in pennselectivity in the
glomerular barrier resulting in proteinuria [14].
The sulfated glycosaminoglycans (heparan sulfate being predominant) in the
glomerular basement membrane constitute anionic sites that regulate the charge selective
barrier, and have been implicated in the pathogenesis of proteinuria occurring in diabetes
and other proteinuric states [76]. Decreased content and synthesis of heparan sulfate
pro teo glycan has been reported in diabetic rats and humans [73,77]. Another study
demonstrated not only a decrease in synthesis of hepa.raIi sulfate proteoglycan in diabetic
glomerular basement membrane, but also a change in the type of heparan sulfate that was
present [11]. The change in the diabetic glomerular heparan sulfate probably represented
a different and newly synthesized beparan sulfate.
From this brief survey, it can be concluded that alterations in GBM composition
occur. However, it is unclear when these changes occur, particularly with respect to the
onset of proteinuria.

D

BASEMENT MEMBRANE ALTERATIONS IN PASSIVE HEYMANN
NEPHRITIS.

Passive Heymann nephritis (PHN) is an animal model that closely resembles human
membranous glomerulonephritis [13]. The characteristics of this disease are thickened
GBM, marked mesangial expansion and severe proteinuria [78]. PHN is induced by
administration of a single injection of anti-FxlA antibody. This antibody, generated in
sheep, is directed against rat tubular brush border and cross-reacts with an antigen on the
surface of glomerular epithelial cells [79]. As a result, subepithelial immune deposits
form and within one week severe proteinuria occurs followed by progressive GBM
thickening and mesangial expansion [13]. GBM compositional studies in PHN are scarce:
Type IV collagen, laminin, fibronectin and entactin have not been quantitated in
glomerular basement membrane from rats with passive Heymann nephritis. However, the
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mRNA levels for collagen IV, laminin and fibronectin were measured and found not to be
different from control values [80]. Although no_ significant differences were measured in
the mRNA levels, this does not preclude the possibility that the protein products or that
assembly of these components were altered in the glomerular basement membrane. Some
support for altered assembly was shown by immunoelectron microscopy of antibodies to
laminin B2 chain. These antibodies stained in a pattern that surrounded the immune
deposits. This suggested that these deposits displaced the GBM resulting in altered
organization of the immediate GBM architecture. Such alterations could then lead to
increased penneability of the GBM.
Some immunostaining studies have been conducted on biopsy tissue of patients
with membranous glomerulonephritis characterizing the distribution of type IV collagen,
laminin and fibronectin in the GBM. In an immunofluorescence study, Fukatsu et al [81]
demonstrated that antibodies to type IV collagen reacted preferentially with the inner and
outer aspects of the thickened GBM, while antibodies to laminin reacted in the same
manner as type IV collagen but additionally reacted with subepithelial OBM spikes and
in newly fonned GBM above the immune deposits. Thus, it was concluded that type IV
collagen and laminin did not codistribute in the newly fonned matrix. Laminin was in
both the subepithelial spikes and in the GBM enveloping the immune deposits.
Fibronectin has been localized in the immune deposits in the GBM as revealed by
immunoelectron microscopy [82].
Another study examined the localization of classical and novel chains of type IV
collagen, laminin B2 chain, fibronectin, and entactin/nidogen during the development of
membranous glomerulonephritis [83]. No difference in staining for the components was
observed at stage I of the disease in which small immune complexes were detected
without morphological changes to the OBM. By stage IT, immune deposits had increased
in size and frrst signs of GBM invaginating (spikes) these deposits were apparent, an
alteration in immunostaining was detected. The subepithelial spikes or projections and
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areas of thickened GBM demonstrated significant staining for the novel chains [a3(1V) &
a4(IV)] of type IV collagen, laminin B2 chain and entactin/nidogen, but no changes in
the staining of classical chains [a 1(IV) & a2(IV)] of type IV collagen or fibronectin. In
stage ill, the immune deposits were completely embedded in the GBM, which displayed
marked thickening. Staining of the aforementioned components continued to increase
with an increase in staining for the classical collagen chains and fibronectin now
demonstrable. In summary, after deposition of immune deposits in the subepithelial side
of the GBM'J this membrane sent projections up and around the deposits.

These

projections consisted predominantly of novel chains of type IV collagen, laminin and
entactin/nidogen that eventually enveloped the immune deposits. Ultimately, this process
yielded a thickened subepithelial GBM with a subsequent increase in the type IV collagen
classical chains and fibronectin in the subendothelial side. The end result was an overall
thickened GBM.
It is interesting to reiterate that Fogel et al [80] detected no changes in mRNA
levels for type IV collagen'J laminin or fibronectin despite the presence of immune
deposits and thickened GBM. This discrepancy may be due to the mRNA analysis not
being sensitive enough to detect an increase; alternatively, the stability of the specific.
mRNAts may have been enhanced resulting in increased translation.
Exploratory work on the heparan sulfate proteoglycan content has been conducted
in a model of human membranous glomerulonephritis [84]. Subepithelial immune
deposits were induced in rabbits by daily administration of cationized bovine serum
albumin. These deposits resulted in thickened OBM morphology with severe proteinuria
after three weeks. It was demonstrated that no change in total glycosaminoglycan content
occurred, but the sulfation state of heparan sulfate was altered. There was a 20%
decrease in incorporated labeled sulfate measured in isolated heparan sulfate despite no
change in the total amount of this glycosaminoglycan. Further study revealed that this
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altered glycosaminoglycan had a lower effective charge and corresponded with a loss of
charge-selective capacity in fractional clearance studies with charged dextrans [84].
This brief historical description is: meant to illustrate the limited and inconclusive
results on glomerular basement membrane compositional alterations in passive Heymann
nephritis.
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Figure 11.1

Structural models of type IV collagen, laminin, fibronectio,

entactin/nidogen and heparan sulfate proteoglycan (adapted from [85]). Bar = 25
om.
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Figure IL2 Schematic representation of the glomerular barrier in the kidney. It
is composed of fenestrated endothelial cells, glomerular basement membrane, and
foot processes of the podocytes/epithelial cells. This remarkable organization
imparts to the kidney the ability to selectively retard the passage of
macromolecules from leaving the capillary lumen based on size and charge. I.r.
int. = lamina rara interna, 1. den.

= lamina densa, I.r. ext. = lamina rara externa.

Drawing kindly produced by Martha L. Brees.
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DI. HETEROGENEOUS MACROMOLECULAR COMPOSITION OF MOUSE
GLOMERULAR AND TUBULAR BASEMENT MEMBRANE
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SUMMARY

Renal glomeruli and tubules were isolated from eight-week-old Swiss-Webster
mice by sucrose-gradient centrifugation. Glomerular basement membrane (GBM) and
tubular basement membrane (TBM) were isolated by sonication in 1% deoxycholate.
GBM and TBM were subjected sequentially to 5M guanidine, 5M guanidine/20mM
dithiothreitol (DTI) , and 2% sodium dodecyl sulfatelDTT (SDS/DTI) extraction
procedures. Electrophoresis revealed a complex mixture of proteins in the guanidine and
guanidinelDTT extracts, while in the SDSIDTT extract, electrophoresis revealed two
strong-staining bands that corresponded to chains of type IV collagen. Immunoblot
analysis demonstrated that among the proteins, laminin and fibronectin were found
exclusively in the guanidine and guanidinelDTI extracts. Laminin and fibronectin were
quantitated in these extracts using inhibitory ELISA. The total amount of laminin
extracted in GBM, 1.8±O.OOI J..1g/mg dry weight (n=2 groups of 53 animals), was
significantly less than in TBM, 3.4±o.1 J.1g/mg dry weight (n 2); however, the total
amount of fibronectin extracted did not differ between GBM and TBM, 8.2±O.8 J.1g1mg
dry weight and 7.7+1.0 flg/mg dry weight (n=2) respectively. We conclude that GBM

and TBM are qualitatively similar but differ significantly in content of one and probably
more macromolecular components.
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INTRODUCTION

A number of macromolecules (laminin [2], fibronectin [3], type IV collagen [1],

entactin [4], and beparan sulfate proteoglycan [5]) have been localized to basement
membranes. Laminin, type IV collagen, and entactin have been shown to assemble into
3-4nm diameter cords which subsequently form a three dimensional mesh-like
architecture [86], while heparan sulfate proteoglycans are believed to act as space filling
molecules and are responsible for the charge selectivity of basement membranes [65]. In
the kidney, it is generally thought that the mesh-like matrix of the GBM is involved in
selectively retarding the passage of macromolecules from the blood to the urinary space.
How the GBM functions as this selective filter is poorly understood. Unfortunately, the
direct study of intact GBM as a selectively permeable barrier is technically not possible
to date. The permeability properties of basement membrane can be directly studied using
intact isolated perfused TBM, possibly as a model for the glomerular barrier [87].
Although it is encouraging to think that the isolated TBM could be used as a model for
the filtering properties of GBM, it is necessary to define the compositions of the two
basement membranes and determine what components, if any, influence the permeability
properties. Thus, understanding similarities and differences between glomerular and
tubular basement membrane may enable the extrapolation of findings in the isolated
perfused TBM to that of the GBM.
Many researchers have used immunocytochemistry to examine the comparative
distribution of basement membrane components. The production of specific polyclonal
and monoclonal antibodies have revealed differences in labeling patterns in GBM and
TBM, suggesting compositional and/or structural heterogeneity exists in these basement
membranes.

Desjardins and Bendayan [14], using specific polyclonal antibodies,

revealed distinct heterogeneity in the distribution of laminin, type IV collagen, entactin,

and HSPG in

GBM~
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mesangial matrix, Bowman's capsule, proximal tubule and distal

tubule basement membrane.
While immunocytochemistry is the ideal technique for localization of specific
basement membrane components, the results can be difficult to interpret in terms of
differences in content: Discrepancies in immunostaining may be a result of routine tissue
fixation masking antigenicity. Furthermore, the absence of immunoreactivity might not
reflect absence of antigen, and the presence of immunoreactivity could result from the
presence of a related antigen.
Mohan and Spiro [15] are the only investigators to report amounts of solubilized
GBM components. In comparing the GBM with the basement membrane of the lens
capsule, they reported that, although laminin, fibronectin, type IV collagen, entactin, and
heparan sulfate proteoglycan were present in the two basement membranes, differences in
the relative amounts of these components were seen. GBM contained more fibronectin
and type IV collagen, and less laminin and entactin than did the lens capsule basement
membrane .
Knowledge from the present study of the macromolecular composition between
GBM and TBM, in conjunction with other studies in our laboratory on the penneability
properties of the TBM, will enable us to begin to assess the functional significance of
differences seen between glomerular and tubular basement membranes.

In this

investigation, we are interested in the similarities and differences between the
compositions of glomerular and tubular basement membranes in mouse kidneys. Using
methods of sieve separation and density gradient centrifugation, intact glomeruli and
tubule fragments were isolated from whole mouse kidneys. After cellular materials were
removed using deoxycholate, glomerular and tubular basement membranes were isolated,
and a sequential extraction procedure was used to solubilize the basement membranes.
To assess compositional differences of unknown proteins, electrophoretic protein profiles
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from extracts of GBM and TBM were compared, while amounts of laminin and
fibronectin in GBM and TBM were quantitated using inhibitory ELISA.
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MATERIALS AND METHODS

Isolation of glomeruli and tubules. All isolation and extraction procedures were at 04°C in the presence of the following protease inhibitors: ImM phenylmetbylsulfonyl
fluoride, ImM EDTA.,

l~g/ml

aprotinin, IJ.1g/mlleupeptin, and IJ!g/ml pepstatin. In each

of two replicate isolation procedures, 53 mice (Swiss-Webster, 61-day-old., male, -22g,
from Charles River) were used. Each animal was killed by cervical dislocation, and both
kidneys were rapidly excised and immediately immersed in chilled phosphate buffered
saline (PBS) containing O.5M sucrose, pH 7.4. Kidneys were decapsulated and the hilus
cut away_ The kidneys were minced with a razor blade and subsequently forced through
a #170 stainless steel sieve (pore size 9OJ.1m) using a metal spatula. The tissue was rinsed
frequently with chilled O.5M sucrose solution while being forced through the sieve. The
glomeruli and tubules were separated using density gradient centrifugation according to
the procedure of Vancura et al [88] (Fig. 111.1). The pure fractions were pooled, washed
three times with PBS (0.I5M NaCI, O.02M phosphate, pH 7.4) and repelleted each time at
48,OOOg for 20 min.

Isolation and extraction of basement membrane. Glomeruli and tubules were
resuspended separately in PBS containing 1% sodium deoxycholate at a volume of
ImV50mg tissue wet weight. Samples were sonicated at 20 watts for lmin/3ml volume
using a Cole-Panner model 4710 ultrasonic homogenizer with a 2mm probe. The
sonications were perfonned stepwise for 1 minute followed by 1 minute of cooling, with
the sample tube always on ice. After sonication the samples were centrifuged at 48,OOOg
for 30 min; the sonication procedure was carried out two more times, and the resulting
basement membrane pellets were transferred to 1.5ml centrifuge tubes, washed three
times with water, and repelleted each time at 16,OOOg. The final GBM and TBM pellets
were lyophilized and weighed.
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GBM and TBM were subjected to sequential extractions according to a procedure
modified from that of Mohan and Spiro [15] (Fig. ill.l). Purified basement membrane
(2mg) was suspended in Iml 5M guanidine hydrochloride, sonicated for 1 minute at 20
watts and extraction continued for three hours at room temperature on an end-over-end
rocker. The samples were centrifuged at 16,OOOg for 20min, and the supernatants
decanted. The pellets were resuspended in Iml of 5M guanidine using brief sonication,
and then extracted overnight at 4°C.

The following morning the samples were

centrifuged and the supernatants collected and pooled with those of the previous day.
The pellets were resuspended in O.5ml of 5M guanidine with O.02M dithiothreitol
(guanidinelDm, and kept at room temperature for three hours on an end-over-end
rocker, and centrifuged. Finally, the pellets were resuspended in O.5ml of 2% SDS,
O.02M OTT, and incubated for 1 hour at 100°C. After cooling, the samples were
centrifuged at 16,OOOg for 20min, and the SDSIDTT extract was decanted leaving small,
insoluble pellets.

Analysis of extracts. SDS polyacrylamide gel electrophoresis was performed using
vertical slab gels [89]. Samples were electrophoresed on 6% gels with an overlying 4%
stacking gel.

Proteins were visualized by silver or transferred to a nitrocellulose

membrane (Schleicher & Schuell) and immunoblot analysis was performed [90]. Briefly,
proteins electrophoresed on SDS-polyacrylamide gels were transferred to a nitrocellulose
membrane for 1 hour, 0.5A, l00V, at 4°C using a Bio-Rad wet transfer apparatus.
Membranes.were equilibrated in tris-saline buffer (65 mM Tris-Hel, 0.5 M NaCI, pH
7.5), for 15 minutes.

Membranes were subsequently blocked in tris-saline buffer

containing 5% nonfat dry milk for 45 minutes, and incubated with a primary antibody for
1 hour. Following three ten minute washes in tris-saline buffer, bound antibody was
detected by an anti-IgG coupled to horseradish peroxidase incubated for 1 hour.
Following three 10 minute washes in phosphate buffered saline, proteins were visualized
by reaction with diaminobenzidine and H202. Molecular weights of electrophoresed
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proteins were estimated by migration relative to (in Oaltoos) prestained standards
ovalbumin, 46,500; serum albumin, 77,000; b-galactosidase, 116,000; and myosin,
205,000 (Bio-Rad, Melville, New York).
Laminin and fibrooectin were quantitated using inhibitory ELISA's [91]. Briefly, flat
bottom 96-well microtiter plates (Costar #3590) were coated with antigen. Specific
antigen was diluted in 0.02M carbonate buffer, pH 9.6, allowed to adsorb to the wells at
lOOf.1Vwell overnight at 4°C. To a second 96-well plate, serial dilutions of soluble
antigen or dilutions of unknown samples, 60 J..1Vwell in phosphate buffered saline
containing 0.05% Tween-20, were pre-incubated with a pre-optimized dilution of
antibody, 6OJ..LVwell in phosphate buffered saline containing 0.05% Tween-20. These
were incubated overnight at 4°C. After allowing the plates to warm to room temperature,
the coated plate was dumped and washed three times with phosphate buffered saline
containing 0.05% Tween-20. Subsequently, 100J..LVwell were transferred from the preincubated plate to the corresponding wells on the coated plate. After a 1 hour incubation,
the plate was dumped, washed three times with phosphate buffered saline containing
0.05% Tween-20. This was followed by the addition of anti-rabbit IgG conjugated to
horseradish peroxidase at 100J.1l/well for 1 hour. The wells were washed three times with
phosphate buffered saline containing 0.05% Tween-20 to remove unbound antibody.
100J..LVwell of ABTS (2-2 azino-di-(3etbyl benzothiazolin sulfone-6)(diammonium salt)
substrate solution in the presence of H202 were added and allowed to react for 30
minutes.

The absorbance of the subsequent color reaction was measured in a

spectrophotometer (Cambridge Series 750 Microplate Reader, Cambridge Technology,
Inc.) at 414 om. Amounts of laminin and fibronectin were calculated from standard
curves using AssayZap 2.0 (BIOSOFf, Ferguson, Missouri).
Total protein of the three extracts was measured using a micro bicinchoninic acid
assay (Pierce) with bovine serum albumin as the standard. Aliquots of the guanidine and
guanidine/DTT extracts were dialyzed against 3M urea to remove guanidine and DTT,

36
which was shown to interfere with the micro BCA assay. Aliquots of the SDSIDTI
extracts were dialyzed against PBS at room temperature to remove the DTf and some
SDS.

Source of antigens & antibodies. Polyclonal antibodies to laminin were raised in
rabbits against laminin purified from EHS tumors [92]. Fibronectin and anti-fibronectin
were from Telios Phannaceuticals (San Diego, California). The anti-rabbit IgO was from
Pierce (Rockford, Illinois).

Statistical Analysis. Analysis of variance was used to determine the significance of
differences among extracts and between GBM and TBM. The statistical analyses were
conducted using JMP 2.0 (SAS Institute Inc., Cary, NC).
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RESULTS
Isolation of glomeruli and tubules. The glomerular fraction consisted of a mixture of
1

capsulated and decapsulated glomeruli (Figures III.2A and ID.3A). By particle count, the
glomerular fraction contained fewer than 8% tubule fragments, which were small,
ranging from 20 - 40 Jl.m in length. The tubular fraction consisted of a mixture of tubule
fragments ranging from 100 - 300 J..lm in length and small clumps of tubules, with less

than 5% glomerular contamination (Figures In.2B and ID.3B).
Sequential extraction of GBM and TBM. Figure ID.4 shows that the percentage of
total protein extracted from GBM was significantly less than that from TBM, 29.9±0.4%
and 42±9.1% (n=2 groups of animals) respectively. In addition, in both the guanidine
and D1T extractions, significantly less protein was extracted from GBM than TBM, thus
reflecting the difference in total protein extracted. No difference was observed in the
amount of SDS/DlT-extracted protein from GBM and TBM. The extraction procedure
affected the distribution of extracted protein such that guanidine accounted for the most
and SDSIDTT accounted for the least in both GBM and TBM (Fig. 111.4). A small
insoluble pellet remained after the extraction procedure.
Electrophoresis and immunoblotting of extracts. Figure ID.S is of a silver stained gel
that revealed different profiles of proteins among the guanidine, DTf and SDS/DTT
extracts for both OBM and TBM. Among the more than 30 bands resolved in the
guanidine extracts, strong staining bands at 200-210kD and at 220kD migrated alongside
the laminin B chains and the reduced chains of fibronectin, respectively. Weaker staining
of bands at about 400kD that migrated alongside the A chain of laminin was seen in the
guanidine extracts for both GBM and TBM. The same silver-stained profile for the A
and B chains of laminin and for fibronectin was observed in the guanidinelDTT extracts;
however, in the SDSIDTT extracts of both GBM and TBM these bands were absent.
Silver staining of the electrophoresed SDSlDlT extracts revealed two strong-staining
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bands that correspond to the al and a2 chains of type IV collagen. The guanidine extract

revealed several bands that stained with different intensities between GBM and TBM
suggesting qualitative differences in composition (shown by arrowheads in Fig. ill.5).
Blots with anti-Iaminin revealed the presence of the two B chains of laminin in the
guanidine and guanidine/DlT extracts of both GBM and TBM (Fig. 111.6). The A chain
of laminin, however, was only detectable in TBM. Staining for the A chain of laminin
was barely detectable in the guanidine extract with much greater staining in the
guanidinelDTI extract. Blots with anti-fibronectin revealed in both guanidine and
guanidine/DTI extracts a doublet, at 220kD, that migrated alongside reduced fibronectin
(Fig. 111.7). The immunoblots probed with anti-Iaminin and anti-fibronectin antibodies
also detected smaller molecular weight bands, presumably fragments, in both GBM and

TBM for the guanidine and guanidine/DTT extracts. No staining was detected on the
immunoblots of the SDSIDTT extracts for either laminin or fibronectin, suggesting
complete solubilization of these components with guanidine and DTT.
Laminin and fibronectin quantitation. Laminin and fibronectin were quantitated in

the guanidine and guanidinelDTI extracts using inhibitory ELISA. The SDSIDTI
extracts were not assayed because of the lack of immunostaining (Figures 111.6 and m.7).
Although the total amount of laminin extracted from GBM and TBM was small, the
amount measured in TBM was two-fold greater than that in GBM (Fig. m.8). With the
addition of DTT to guanidine, only a small amount of laminin was additionally extracted
from GBM and TBM;

conversely, the amount of fibronectin extracted with

guanidine/D'IT was much greater than the amount extracted with guanidine alone,
suggesting fibronectin contains a higher degree of reducible cross-links to other
components of basement membrane. The total amounts of fibronectin extracted did not
differ between GBM and TBM (Fig. 111.8).
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DISCUSSION

The method of using sucrose gradients proved to be very successful in separating
pure fractions of glomeruli and tubules from the same mouse kidney [11]. For the
isolation of mouse GBM and TBM and rat GBM, we modified the sonication method of
Spiro [10] by incorporating an anionic detergent, deoxycholate. To our knowledge this is
the frrst time sonication in the presence of deoxycholate has been used for the isolation of
basement membrane.

Solubilization of basement membranes. Not all of the deoxycholate-insoluble
material (GBM & TBM) was solubilized in this study, but the residual pellets were small
compared to starting materials. Mohan and Spiro [15], reported that a small amount of
bovine GBM was insoluble to these -denaturing and reducing agents. Kefalides [59],
reported that the most successful approach to solubilizing-without degrading-basement
membranes, was the reduction of disulfide bonds in the presence of strong denaturants.
The incomplete solubilization of GBM and TBM suggests that these basement
membranes contain a high degree of nonreducible cross-links resulting in insoluble
structures.
In the present investigation, bands corresponding to laminin A and B chains and
fibronectin were apparent in the guanidine and guanidine/DTf, but not in the SDS/DTT
extracts. Electrophoresis also revealed the presence of 6 bands, presumably unknown
proteins, with molecular weights ranging from 58-190kD that appeared to be in greater
amount in TBM than GBM; while 2 bands were shown to stain more strongly in GBM as
compared to TBM (Fig. 5). The absence of staining for these bands in immunoblots
suggested that these lower molecular weight bands were not fragments of laminin or
fibronectin, while the differential silver-staining suggests differences in the relative
amounts of these proteins between GBM and TBM. The few strong-staining proteins
resolved in the SDSIDTf extracts migrated alongside the al and a2 chains of type IV
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collagen, suggesting that this extract contains reduced type IV collagen. This observation
is supported by the findings of Mohan and Spiro [15], who concluded that essentially all
non-collagenous macromolecules were solubilized in the guanidine and DTT extracts
leaving a collagenous pellet that was relatively soluble in SDSIDTT.
From immunoblot analysis in this study, laminin B chains were present in both
GBMand TBM, whereas the A chain of laminin could only be detected in TBM. This
indicates that the A chain of laminin, if present, may exist in an amount that is
insufficient to detect. Kleinman et al [93] demonstrated that different subunit structures
of the laminin molecule exist in tissues: B 1 chain mRNA levels were highest in whole
kidney with little A chain mRNA. Furthermore, the lack of staining for A chain of
laminin in GBM may also imply that an isoform of this chain may exist in GBM that is
not present in TBM. Sanes et al [33], showed heterogeneity in the distribution of
s-laminin, an isofonn of laminin Bl chain7among renal basement membranes: s-laminin
was present in

ra~

human 7 and rabbit GBM but not TBM of the same species. The

immunoblots revealed the presence of fibronectin in both GBM and TBM.

Quantitation of laminin and jibronectin. The total amount of laminin measured in
the GBM was half that of TBM.

Similarly, Courtoy et al [94] using

immunocytochemistry, reported a lesser amount of laminin present in GBM as compared
to TBM. The amount of laminin we measured in mouse GBM7 1.8J.1g/mg7 was very
similar to the amount reported by Mohan and Spiro [15] from bovine GBM7 1.6J.1g/mg.
No differences were found in the amounts of fibronectin extracted from GBM and TBM.
This is in contrast to results of Courtoy et al [94] who showed immunostaining for
fibronectin was more intense in GBM than TBM. The amount of fibronectin reported by
Mohan and Spiro [15] from bovine GBM, 11.3J.1g/mg7 was slightly greater than our
measurement from mouse GBM7 8.2J.1g/mg.
In summary, we see differences in composition between mouse GBM and TBM.
Laminin content is higher in TBM, and electrophoretic profiles suggest that quantitative
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differences exist between TBM and GBM in the content of other proteins as welL Thus,
penneability work with isolated basement membrane from tubules cannot automatically
be extrapolated to the basement membrane in the filtration barrier of the glomerulus [87].

On the other hand, we do not know if differences in laminin content (for example) would
affect basement membrane penneability. Clearly, more work in this area is needed if we
are to understand the relationship between the composition and penneability of basement
membranes.
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Figure 111.1 Method for the separation of glomeruli and tubules followed by
isolation and subsequent sequential extraction of the glomerular and tubular
basement membranes.
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Figure Ill.2 Digitized video images captured from bright field light microscopy
of suspensions of A: glomeruli purified on 1.74M/2.0M sucrose gradient, and B:
tubules purified on 1.SM/l.6M sucrose gradient. Bar =50J,lm.

Figure 111.2

A

B
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Figure 111.3 Digitized video images captured from high magnification bright
field light microscopy of a single A: glomerulus purified on 1.74M/2.OM sucrose
gradient, and B: tubule purified on 1.5M/l.6M sucrose gradient. Bar = 15J.1m.

A

B
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Figure 111.4 Distribution of protein in sequential extracts of GBM and TBM.

Mouse GBM and TBM were treated sequentially with 5M guanidine, 5M
guanidine/20mM 011, and 2% SDSID1T as described in methods. The graph
indicates for each treatment the percentage of protein extracted based on initial
dry weight of basement membrane. Values are means + standard error, n = 6. G

= glomerular basement membrane (solid bars), T = tubular basement membrane
(hatched bars).
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Figure Ill.5 Solubilized components of GBM and TBM. Equal quantities (about
3flg/lane) of guanidine (Gu), guanidine/DTI, and SDS/DTI extracts of GBM and

TBM were electrophoresed on 6% vertical polyacrylamide slab gels in the
presence of a reducing agent Positions of molecular weight markers are shown to
the left.
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Figure 111.6 Laminin in GBM and TBM extracts.

Guanidine (Gu),

guanidine/DTf, and SDSIDTT extracts were electrophoresed as in Fig. 111.5; the
immunoblot was reacted with anti-laminin antibodies.
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Figure 111.7 Fibronectin in GBM and TBM extracts.

Electrophoresis and

transfer procedure are identical to that of Fig. ill.6 Immunoblot was reacted with
anti-fibronectin antibodies.
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Figure 111.8 EliSA measurement of laminin and fibronectin in mouse GBM and
TBM.

Laminin and fibronectin were quantitated in the guanidine and

guanidine/DTT extracts of GBM and TBM. Bars indicate the total amounts of
laminin and fibronectin measured while the solid areas reveal the amounts
measured in the guanidine and the hatched areas reveal the amounts measured in
the guanidine/DTf. Values are means + standard error, n = 8. * p<O.05, GBM vs
TBM.
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IV. DIFFERENTIAL EFFECTS OF EXPERIMENTAL DIABETES AND
GLOMERULONEPHRITIS ON GLOMERULAR BASEMENT MEMBRANE
COMPOSITION
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SUMMARY

The hallmark of renal diseases involving the glomerulus is the presence of
proteinuria. While the pathogenesis of proteinuria has not been established, alterations in
the charge barrier as well as the size barrier of the glomerular basement membrane
(GBM) have been implicated. We evaluated the acute effect of streptozotocin diabetes
and passive Heymann nephritis (PHN) on the macromolecular composition of rat GBM
to detennine if changes in composition correlate with proteinuria in these two models of
kidney disease. Six to twelve rats from each group (control, diabetic, and PHN) were
killed 1, 5, 28, 56, 84 days after administration of injections. Identical amounts of GBM
were subjected to a sequential extraction procedure and type IV collagen, entactin,
laminin., fibronectin., and anionic charge content were quantitated in the extracts.
ANOVA for type IV collagen content revealed no effects of time or disease; type IV

collagen content averaged 29.1+1.2 Jig/mg dry GBM (Average of values from control,
diabetic, and PHN at all five time points). Entactin also did not change., and averaged
7.7±O.5% of type N collagen content. Both laminin and fibronectin contents increased
with time in GBM, including control, and this increase was significantly greater in
diabetic GBM. Detectable at day 28, a significant decrease in anionic charge content of
diabetic GBM coincided with the onset of proteinuria. In PHN, no differences in type IV
collagen, entactin, laminin., fibronectin or anionic charge content of GBM were found
compared with control even though profound proteinuria was evident in PHN from day 5
on. In diabetic rats, the increase in laminin content over control

pr~ceded

the onset of

proteinuria, while the increase in fibronectin was not apparent until after proteinuria had
begun. Although the changes in diabetic GBM glycoprotein content did not correlate
directly with the presence or absence of proteinuria, the decrease in anionic charge
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content did. Thus, control GBM was found to change its laminin and fibronectin content
with age, while type IV collagen content and anionic charge remained constant. In
diabetic GBM, an increase in laminin content and decrease in anionic charge are both
candidates for alterations that could lead to proteinuria. In contrast, PHN resulted in
profound proteinuria with no changes in GBM content. Thus, while GBM alterations

may be important for development of proteinuria in streptozotocin diabetes, such changes
are not involved in PHN.
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INTRODUCTION

In insulin dependent diabetes mellitus, loss of selective permeability with proteinuria

constitutes one of the major characteristics of diabetic nephropathy. It is believed that
progressive accumulation of glomerular extracellular matrix, both glomerular basement
membrane and mesangial matrix, is an important "aspect of the defect that leads to
proteinuria and ultimately to glomerular sclerosis with loss of functioning filtration units
[59]. It is commonly assumed that morphological and functional alterations of the
glomerular basement membrane in human and experimentally induced diabetes must be
accompanied by changes in their macromolecular composition and structure [67]. While
the pathogenesis of proteinuria has not been established, alterations in the charge as well
as the size barrier of the glomerular basement membrane have been implicated as playing
an intimate role in increased permeability [95].

Type IV collagen, laminin and

fibronectin content were altered during different stages of diabetes [96]; however, very
little is known about the content of these specific macromolecules during the acute stage
of diabetes with respect to the onset of proteinuria.
Similarly, passive Heymann nephritis, an animal model that closely resembles
human membranous glomerulonephritis, displays thickened glomerular basement
membrane, marked mesangial expansion and severe proteinuria [78].

PHN is

immunologically induced by administration of a single injection of anti-FxlA antibody.
This antibody is directed against rat tubular brush border and cross-reacts with an antigen
on the surface of glomerular epithelial cells [79]. As a result, subepithelial immune
deposits form and within one week severe proteinuria occurs followed by progressive
GBM thickening and mesangial expansion [13].
Thus, in diabetes mellitus and passive Heymann nephritis, damage to the glomerular
barrier occurs and is accompanied by an increase in penneability to proteins the size of
albumin and larger. The present study was designed to detennine if any changes in the
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macromolecular composition of glomerular basement membranes occur in these two

models of kidney disease and if compositional changes correlate with the onset of
proteinuria.
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METHODS

Experimental animals. 162 age-matched male Sprague Dawley rats (Harlan Sprague

Dawley, Inc., Indianapolis, Indiana), weighing 217+1g were divided randomly into three
groups. Diabetes was induced in the fIrst group by a single intravenous injection of
streptozotocin (60 mg/kg body weight in sodium citrate buffer, pH 4). Passive Heymann
nephritis was induced in the second group by a single intraperitoneal injection of antiFxlA antibody. The third group of 54 rats served as the controls, receiving a single
intraperitoneal injection of saline. For each of the three groups, rats were killed at the
following times' post-injection: 1 day (n = 12); 5 days (n = 6); 28 days (n
(n

= 10-12);

and 84 days (n

= 9-12).

= 12); 56 days

The following physiologic measurements were

made prior to death: body weight; serum glucose using a glucose analyzer 2 (Beckman,
Palo Alto, California); and 24-hour urinary albumin using an inhibitory ELISA. Serum
glucose levels were measured in the diabetic rats weekly_ To maintain these

l~vels

between 500 and 600 mgldl, all diabetic rats with levels greater than 450 mg/dl received a
daily low-dose subcutaneous injection of 0.1 unit Lente insulin (Eli Lilly and Co.,
Indianapolis, Indiana). All animals were housed in the same room, received the same
standard chow and bad free access to water. Rats were anesthetized with sodium
pentobarbital prior to removal of kidneys and then killed by celVical dislocation.

Renal histology. Kidneys from control, diabetic and PHN rats at one and three
months were used for histology_ Immediately after removal of kidneys, thin coronal
sections were made. These sections were immersion-fixed for two hours in Bouin's
solution, transferred into 70% ethanol, embedded in paraffin, sectioned and stained with
silver [97].

Isolation and extraction of glomerular basement membrane. All isolation and
extraction procedures were at 0-4°C in the presence of the following protease inhibitors:
ImM pbenylmethylsulfonyl fluoride, ImM EDTA, lJ..lg/ml aprotinin, IJ..lg/mlleupeptin,
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and IJ..lg/ml pepstatin. At each time point, the rats within each of the three groups were

divided into two groups and batch processed. Kidneys were excised, decapsulated and
the cortex was cut away . Glomeruli were separated from cortices using standard sieving
procedures [98] (Fig. IV.l). Briefly, tissue was minced, then forced through a #170
stainless steel sieve, pore size 9OJ.lm, while being rinsed frequently with chilled PBS
solution. Lastly, the sievings were poured onto sequential sieves of 180, 150, 75, and 63
Jlm pore sizes with the glomeruli collecting on the 75 and 63 J,lffi sieves. When viewed,
the glomerular fraction contained a mixture of capsulated and decapsulated glomeruli
with less than 5% contamination by small tubular fragments (Fig . N.2).

Glomeruli were resuspended separately in PBS containing 1% sodium deoxycholate
at a volume of lmU50mg tissue wet weight. Samples were sonicated at 20 watts for
lmin/3ml volume using a Cole-Panner model 4710 ultrasonic homogenizer with a 2mm
probe. The sonications were performed stepwise for 1 minute followed by I minute of
cooling, with the sample tube always on ice.

After sonication the samples were

centrifuged at 48,OOOg for 30 minutes. The sonication procedure was carried out two
more times, and the resulting basement membrane pellets were transferred to 1.Sml
centrifuge tubes, washed three times with water, and repelleted each time at 16,OOOg.
The final GBM pellets were lyophilized and weighed.
Glomerular basement membrane was subjected to sequential extractions according to
a procedure modified from that of Mohan and Spiro [15] (Fig. IV.I). Purified GBM
(2mg) was suspended in Iml 5M guanidine hydrochloride, sonicated for I minute at 20
watts and extracted for three hours at room temperature on an end-over-end rocker.
Samples were centrifuged at 16,OOOg for 20min, and the supernatants decanted. The
pellets were resuspended in 0.5ml of SM guanidine with 0.02M dithiothreitol
(guanidinelDTT), and kept at room temperature for three hours on an end-over-end
rocker, and centrifuged. Finally, the pellets were resuspended in O.Sml of 2% SDS,
O.02M DTT, and incubated for 1 hour at 100°C. After cooling, the samples were

65
centrifuged at 16,OOOg for 20min, and the SDSID1T extract was decanted leaving small,
insoluble pellets.

Analysis of extracts. Total protein of the three extracts was measured using a micro
bicinchoninic acid assay (Pierce) with bovine serum albumin as the standard. Aliquots of
the guanidine and guanidine/D1T extracts were dialyzed for 72 hours against 3M urea to
remove guanidine and DTf, which was shown to interfere with the micro BCA assay.
Aliquots of the SDSIDTf extracts were dialyzed for 72 hours against PBS at room
temperature to remove the DTf and most of the SDS.
SDS polyacrylamide gel electrophoresis was performed using vertical slab gels [89].
Samples were electrophoresed on 6% gels with an overlying 4% stacking gel. Proteins
were visualized by silver or transferred to a nitrocellulose membrane (Schleicher &
Schuell Inc., Keene, New Hampshire) and immunoblot analysis was performed [90].
Type IV collagen, laminin, fibronectin and entactin were quantitated using inhibitory
ELISA's [91]. Briefly, 96-well microtiter plates (plate #3590, Costar Corp., Cambridge,
Massachusetts) were coated with antigen. Specific antibody was incubated overnight
with known quantities of the antigen or dilutions of unknown samples. The wells were
rinsed, then anti-IgG conjugated to horseradish peroxidase was added. Bound antibody
was detected colorimetrically using 2-2 azino-di-(3ethyl benzothiazolin). Amounts of
type IV collagen, laminin, fibronectin and entactin were calculated from standard curves

using AssayZap 2.0 (BIOSOFf, Ferguson, Missouri).
Anionic charge content of the GBM was quantitated from scanned images of dot
blots stained with alcian blue [99]. Known amounts of heparan sulfate (Sigma Chemical
Co., St Louis, Missouri) and samples from the 5M guanidine extracts were reacted with
Immobilon-N membrane (pore size: O.45J.lm; Millipore Corp., Bedford, MA) in a dotblot apparatus for 15 minutes. Another identical group of known and unknown samples
were treated with nitrous acid for 15 minutes on ice prior to reacting with membrane.
Following a brief rinse with PBS under vacuum, the membrane was removed from the
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apparatus and allowed to soak for 30 minutes in PBS containing 0.5% tween 20, pH 7.4.
The membrane was then stained for 20 minutes with

~e

following: 0.2% alcian blue,

O.05M Na acetate, 0.05 M MgCI2, and O.05M NaCI, pH 5.7. After drying, the membrane
was digitized using a flatbed scanner (HSD Scan-X, HSD) and a Macintosh IIfx
computer. Densitometric analysis was performed using Image 1.41 program (NIH,
Bethesda, Maryland).

Source of antigens & antibodies. Rat serum albumin (used for albumin ELISA) was
from Sigma Chemical Co. (St Louis, Missouri). Polyclonal antibodies to rat serum
albumin were generated in rabbits using rat serum albumin (Sigma Chemical Co., St
Louis, Missouri). Polyclonal antibodies to type IV collagen were the generous gift of Dr.
Kevin McCarthy, University of Alabama (Binningham, Alabama). Polyclonal antibodies
to laminin were the generous gift of Dr. Dale A. Abrahamson, University of Alabama
(Birmingham, Alabama).

Fibronectin and anti-fibronectin were from Telios

Pharmaceuticals (San Diego, California). Entactin and anti-entactin were from Upstate
Biotechnology, Inc. (Lake Placid, New York). The anti-rabbit IgG was from Pierce
(Rockford, Illinois). Specificity of these antibodies were tested using inhibitory ELISA

as shown in figure IV.14.

Statistical Analysis. Comparisons among the different groups at each time point
and over the course of the study were made by analysis of variance using the TukeyKramer HSD test The statistical analyses were conducted using JMP 2.0 (SAS Institute

Inc., Cary, NC) and significance was assigned at the P < 0.05 level.
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RESULTS
Experimental animals. Mean values from rats killed 1, 5, 28, 56, and 84 days after
injection for body weight, serum glucose, kidney weight to body weight ratio, and dry
GBM weights are summarized in Table IV.I. At the time of injection, the body weights
of the control, diabetic and PHN rats were not different (control = 218.9±I.3g; diabetic

=

216.8+1.3g; PHN = 216.4+I.3g). Weight gain in the diabetic and PHN rats was less than
that of control rats from day 28 through day 84; however, the reduced rate of weight gain
was exacerbated in the diabetic rats. Twenty-four hours after injection of streptozotocin,
serum glucose levels were elevated significantly as compared to control and PHN rats.
These levels continued to increase and then stabilized between 500-600 mg/dl with the
low-dose insulin therapy throughout the study. All of the stretozotocin injected rats for
the 28, 56, and 84 day time points received daily low dose injections of insulin. Wet
kidney weights corrected for body weight were significantly greater in both the diabetic
and PHN versus control rats from day 5 through day 84. There was a significant increase
in the ratio of dry OBM to wet weight cortex with time, while disease had no effect on
this ratio.
Silver-stained histological preparations of control, diabetic and PHN rat kidneys
from one month (Fig. IV.3) and three months (Fig. IV.4) demonstrated no striking
morphological differences among the control, diabetic and PHN rats or between the two
time points. The physiological measurements for these rats are in Table N.2. Because
only one rat from each group was used, no statistical tests were executed; however, the
increased serum glucose for the one and three month diabetic rats over control rats can be
appreciated. Profound increases in urinary albumin excretion rate were seen in the one
and three month PHN rats. The diabetic rats at one and three months showed urinary
albumin excretion rates that were elevated over age-matched control rats.
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Values for sequential determinations of urinary albumin excretion rate for each
group are illustrated in figure IV.5. There was no difference in albuminuria on day one
among the three groups. By day five overt proteinuria had developed in rats with passive
Heymann nephritis, but there was no significant change in albuminuria in the control or
diabetic groups. By day 28 there was a further significant increase in urinary albumin
excretion to 575 mglday in the PHN group and urinary albumin excretion rate remained
in this range on day 56 and day 84. Albuminuria was significantly increased in both the
control and~ diabetic groups by day 28, but was significantly greater in the diabetic group
than in the control group. There was a further increase in albuminuria in the diabetic
group between day 28 and 56, but urinary albumin excretion rate remained constant
between days 56 and 84. In contrast, there was no further change in urinary albumin
excretion between days 28 and 56 or days 56 and 84 in the control group.

Analysis of extracts. The distribution of total extracted GBM protein from control,
diabetic, and PHN rats is shown in Figure IV.6. Neither time nor type of extraction
affected the amount of protein extracted among the control, diabetic and PHN groups.
However, within each of these groups the amount of protein extracted significantly
decreased with subsequent extractions:

guanidine extracted the greatest amount

(J.l=425f..lg/mg GBM) and SDSIDTf extracted the least (J.l=270J.Lglmg GBM).
Electrophoresis of GBM extracts revealed complex electrophoretic protein protiles
among the guanidine, OTf, and SOSlDlT extracts. Silver staining of the guanidine
extracts revealed numerous bands ranging from 220 kD down to 45 kD (the dye front)
(Fig . IV.7). Among these bands were some faintly detectable bands that migrated
alongside laminin B chains, fibronectin and entactin. No obvious differences in staining
of these were detected with time or between control, diabetic and PHN rats. A strongstaining band at 90 kO in all three groups migrated alongside a fragment of the cellular
fonn of fibronectin. Furthennore, all three groups revealed a strong staining band at 100
kD that migrated alongside a fragment of entactin.. The presence of these low molecular
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weight bands suggest that proteolysis of fibronectin and entactin occurred in the presence
of protease inhibitors.
Figure IV.S shows the guanidine/DTf extracts that revealed numerous bands whose
range extended that of the guanidine to include bands up to 400 kD. Two very intensely
stained bands~ one at 190 and the other at 210 kD~ were observed in all three groups. The
210 kD band migrated alongside the laminin B chains and the 190 kD band migrated
alongside a large fragment of fibronectin. A doublet at 400 - 440 kD was observed in all
three groups. These two bands corresponded to the migration of laminin A chain (400
kD) and dimeric fibronectin (440 kD). Several strong staining small molecular weight
bands, specifically 45, 55 and SO kD were detected in control, diabetic and PHN samples.
However, the intensity of staining was different among the three groups at each time
point. PHN showed the strongest staining and diabetic showed the weakest for these
three bands.

Figure IV.9 shows that the SDSIDTT extracts revealed essentially only high
molecular weight bands that ranged from 350 down to 120 kD. Among these were two
bands that migrated alongside the two alpha chains of type IV collagen, while a band at
350 kD migrated alongside a band in the type IV collagen standard lane. This 350 kD
may reflect oligomeric fonns of type IV collagen.
Immunoblot analysis revealed that among these complex mixtures of proteins, type
IV collagen was solubilized exclusively in the guanidinelDTT and SDS/DTf extracts

while the glycoproteins, namely laminin, fibronectin and entactin were solubilized
completely in the guanidine and DTT extracts. Figure IV.I0 shows immunoblots probed
with type IV collagen antibodies from the five time points.

Compared to the

guanidine/DTT extracts, the SDSIDTf extracts revealed stronger staining at each of the
five time points. This suggested that a greater amount of type IV collagen was extracted
with SDS/DTT. No striking differences in staining were detected with time or between
the control, diabetic and PHN rats. In addition to the alpha chains and oligomeric fonns
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of type IV collagen, there were numerous small molecular weight bands that stained.
These bands were presumably fragments of type IV collagen as indicated from staining
with anti-collagen IV antibodys in immunoblots.
Figure IV.II shows immunoblots of extracts from control, diabetic, and PHN GBM's
probed with laminin antibodies. Only very faint staining was detectable for laminin B
chains in the guanidine extracts. Similarly, the silver-stained gels revealed very faintstaining of bands at 200 - 220 kD that corresponded to laminin B chains.

The

guanidinelDTf extracts reveal exclusive staining for the laminin B chains. These results
suggested that the laminin A chain was not present or present but below the detection
limit of the assay.
Figure IV.12 shows immunoblots of extracts from control, diabetic, and PHN GBM's
probed with fibronectin antibodies. No staining for monomeric fibronectin (220 kD) in
the guanidine extracts was detected; however, several small molecular weight bands
were stained and one of these bands stained very prominently, 100 kD. Thus, the lack of
monomeric fibronectin in the presence of immunoreactive fragments suggested that
proteolysis of this protein occurred during its extraction with guanidine.

The

guanidine/DTf extracts revealed strong staining at 220 kD that corresponded with the
monomeric fonn of fibronectin, and a few large fragments of fibronectin in all three
groups at each time point
Figure IV. 13 shows immunoblots of extracts from control, diabetic, and PHN·GBM's
probed with entactin antibodies. The guanidine extracts at days 1, 5, 28 and 56 revealed a
doublet at 90 leD with the lack of staining for entactin at 150 kD. However, day 84
revealed staining of bands at 150, 100 and 90 kD. The band at 150 kD stained very
faintly while the 100 kD band stained more strongly. This 100 kD band, as described
above, corresponded to an entactin fragment in the silver stained gels. Furthennore, a
100 kD band that corresponded with the entactin fragment was stained in the laminin
standard lane..

This band has been shown to be a breakdown product of EHS
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entactin/nidogen, which is highly susceptible to proteolysis (Dr. Roy C. Ogle, personal
communication). Thus, these results suggest that proteolysis of entactin occurred during
its isolation with guanidine. The guanidine/DlT extracts revealed strong staining of
entactin at 150 kD with some staining of fragments. No striking differences were
observed for entactin with time or between the control, diabetic and PHN rats.
The amount of type IV collagen was measured in both the guanidinelDlT and
SDSlDlT extracts as shown in figure IV.I5. SDS/DlT extracted 50% more type IV
collagen than that extracted with guanidine/DTf. The total amount of type IV collagen
did not change as a function of time or disease as determined by ANOV A; type IV
collagen content averaged 29.1+1.2 J..lg/mg dry GBM. Even though no significant
differences were measured for type IV collagen, there was some variability in the
measured amounts between control, diabetic, and PHN GBM. This variability may
reflect small differences in weighing out the 2 mg of lyophilized GBM before extractions.
Therefore, to take into account any differences in weight of GBM starting material, the
measured amounts of the glycoproteins laminin, fibronectin and entactin were normalized
to type IV collagen.
Laminin measured in the combined guanidine and DlT extracts increased with time
in all groups: control, 4.6±O.2 to 8.2±O.1 J,.lg/mg dry GBM (days 1 to 84); diabetic,
3.5±O.2 to 12.0±0.07 J.1g/mg; PHN, 3.6±O.05 to 10.5±O.3 J,1g/mg. However, the increase
in laminin was greater in magnitude for the diabetic GBM as compared to control and
PHN starting on day 5 (Fig. N.16). Although the fIrst measurable increase in laminin in
diabetic GBM occurred prior to the onset of proteinuria (day 28; Fig. IV.5), the greatest
increase occurred between days 28 and 56, just after proteinuria was observed. By day
84, the increased laminin content appeared to have peaked, paralleling the plateau
observed for proteinuria. The measured amount of laminin in the PHN GBM revealed no
significant differences compared to control GBM at any time point.
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Fibronectin measured in the combined guanidine and DTT extracts of diabetic GBM
showed a significant increase at day 56, coinciding with the dramatic increase in laminin
but occurring after the establishment of proteinuria (Fig. IV.17). The fibronectin content
continued to increase and exceeded the amount of type IV collagen (by 6±3%) by day 84
(fibronectin

conten~

days 1 vs 84

= 4.3±O.09

to 30.0±0.4 J,1g/mg dry GBM).

The

measured amount of fibronectin in the PHN GBM revealed no significant differences
compared to control GBM at any time point (days 1 to 84, control

= 7.2±O.3 to 9.0±0.1

flg/mg dry GBM, PUN = 7.2±0.4 to 8.8±O.2 J.lg/mg).
Entactin measured in the combined guanidine and DTT extracts did not change as a
function of time or disease (Fig. IV.I8). The entactin content averaged 1.1±O.06 Jlg/mg
dryGBM.
Anionic charge content of the GBM was estimated by densitometric analysis of dot
blots stained with alcian blue as illustrated by a typical blot in Figure IV.19. Alcian blue
staining was significantly decreased in diabetic GBM as compared to control and PUN.
This decrease was evident by day 28 and correlated with the onset of proteinuria in
diabetic rats. Alcian blue staining remained significantly diminished throughout the time
course for the diabetic GBM. Alcian blue staining of extracts from PHN glomeruli did
not differ with time or from control GBM.
Figure IV.20 shows a densitometric analysis of nitrous acid treated samples prior to
staining blots with alcian blue. The nitrous acid treatment selectively degrades heparan
sulfate glycosaminoglycan chains. Nitrous acid pretreatment showed decreased alcian
blue staining that was not different between control, diabetic and PHN GBMs at days 1
and 5. Alcian blue staining was greatly reduced in both control and PHN GBMs from
day 28 on whereas the reduced staining in diabetic GBM was less dramatic.
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DISCUSSION

We compared the acute stages of diabetes and passive Heymann nephritis regarding
proteinuria and changes in GBM macromolecular composition namely, type IV collagen,
laminin, fibronectin, entactin and anionic charge content. Results showed profound
alterations in GBM composition during the course of diabetes, however, no changes were
detected in GBM macromolecular composition during the course of PHN.
A characteristic feature of insulin dependent diabetes mellitus is thickened GBM. It
has been suggested that an increased synthesis and accumulation of type IV collagen,
laminin and fibronectin are responsible for the thickening [64,96]. However, these
studies have not precisely defined when increases occurred in relation to the onset of
proteinuria in diabetes. The streptozotocin-injected rats displayed metabolic changes
related to diabetes, namely severe hyperglycemia, polyuria, proteinuria and significant
reduction in growth rate. However, morphologically no differences were noted at one or
three months in the diabetic glomeruli versus control glomeruli.

Morphological

alterations in diabetic GBM were detectable by eight to twelve months using electron
microscopy [100]. Therefore, our findings with light microscopy are consistent with the
view that marked thickening of the GBM is not apparent in the early stages of diabetes in
this model.
In the present study, the acute stages of diabetes had no effect on type IV collagen
content. It is generally accepted that type IV collagen is increased in human diabetic
GBM [11]. However, this belief reflects long-te~ effects of diabetes on glomeruli from
both human and experimental animals. In contrast, acute studies revealed a delayed
induction of type IV collagen synthesis in models of diabetes. Ledbetter et al [101]
measured the mRNA levels of the classical chains of type IV collagen [al(IV), a2(IV)]
in the cortices of spontaneously diabetic KKAy mice; mRNA levels were unchanged
after one and two months with a two-fold increase detectable at four months. In addition,
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Ihm et al [102] using isolated glomeruli from streptozotocin diabetic rats detected no
changes in glomerular al(IV) mRNA levels at one week or one month. Collectively,
these data indicate a lack of change in the amount of type IV collagen during the onset of
experimental diabetes, thus suggesting a delayed induction of type IV collagen synthesis.
It is unclear if proteinuria has any effect on this increased type IV collagen production.
It has been shown that diabetic GBM becomes less soluble with disease progress.
Specifically type IV collagen was more resistant to proteolysis and extraction techniques
[103,104]. Our results showed that no differences were apparent in the amounts of total
protein extracted from control, diabetic and PHN GBM. Although SOS-PAGE revealed
complex protein profiles among the guanidine, 017, and SOS extracts, there were no
striking differences in these profiles between control, diabetic and PHN extracted GBM.
Furthermore, there were no differences among these electrophoretic protein profiles with
time. Collectively, these results suggest that the lack of differences in type IV collagen
content were not due to proteolysis or decreased solubility of GBM or collagen.
Other studies of laminin content in human diabetic GBM have revealed a differential
expression during the disease:

Early and intermediate stages showed increased

immunostaining for laminin with a diminution in this staining during the late severe
stages [96,105]. The results presented here and in conjunction with those of Spiro and
coworkers are consistent with a differential expression of laminin content during
diabetes. Our findings demonstrated a 35 % increase in laminin content during the acute
stages while Spiro and coworkers showed a 40% decrease in late severe stages of human
diabetes. In addition, cultured mesangial cells grown in high glucose concentration after
one week, revealed a 40 - 50 % increase in laminin Bl chain mRNA with a subsequent
50 % increase in secreted laminin after one month [106]. Thus, the results described
herein suggest that hyperglycemia affects the synthesis of laminin during the acute stages
of diabetes. Although the increased laminin content was initially detectable at day 5, a
more pronounced increase occurred during the interval immediately following
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proteinuria. Taken together, these results suggest that proteinuria exacerbates the
hyperglycemic-induced increase in laminin. Interestingly, the control GBM displayed
increased laminin content on days 56 and 84 that was significantly greater than days 1, 5
or 28. Prior to this increase in laminin content, the control rats displayed proteinuria,
although not as significant as the diabetics. Thus, perhaps laminin is involved in the
progression of proteinuria.
Data for fibronectin content in human and experimental diabetes are conflicting.
Some studies revealed no changes in amount of fibronectin in late severe stages [12],
while others reported significant increases after six weeks [107].

Furthermore~

mesangial

cells grown in high glucose concentration revealed increased fibronectin secretion and
mRNA levels after one week, suggesting hyperglycemia has a direct effect on fibronectin
production [106]. Our findings revealed a profound increase in fibronectin content
during the interval immediately following proteinuria. Collectively, these contradictory
fmdings suggest that altered fibronectin production increases after the onset of proteinuria
with subsequent decreases in the late severe stages of the disease. This suggests a
similarly altered differential expression during the progression of diabetes as suggested
for laminin. The concomitant massive increases in laminin and fibronectin during the
interval immediately following proteinuria might be a result of a compensatory
mechanism to restore normal filtration.
Similar to type IV collagen, diabetes had no effect on entactin/nidogen content.
Examination of entactin/nidogen in diabetic kidneys was, until now, limited to
immunostaining. Immunohistochemical studies revealed in early stages of diabetes
prominent entactin/nidogen staining in mesangium where mesangial expansion was
present [108]. This mesangial staining disappeared with progression of the disease;
however, thickened GBM showed an increased entactin/nidogen staining. Amounts of
entactin/nidogen have not been measured in diabetic GBM. In the acute assessment of
GBM composition described herein, quantitation of entactin/nidogen revealed no effects

of disease or time.
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Thus, in conjunction with immunohistochemical studies,

entactin/nidogen does not appear to be altered during acute stages, but may be affected
with progression of diabetes.
The physiological relevance of type IV collagen, laminin, fibronectin, and entactin in
the glomerular barrier is unknown. However, the functional significance of the anionic
charge barrier with the normal filtration properties of the GBM has been demonstrated.
Kanwar showed that a reduction in one of the anionic constituents of GBM, heparan
sulfate, resulted in altered charge permselectivity of the GBM with subsequent
proteinuria [65].

It is commonly accepted that the content of heparan sulfate

glycosaminoglycan chains and heparan sulfate proteoglycans are diminished in the early
stages of diabetes.

Additionally, selective degradation of heparan sulfate

glycosaminoglycan chains did not greatly decrease the alcian blue staining; however,
nitrous acid pretreatment revealed marked decreased staining for control GBM samples.
In the diabetic GBM, this suggested that the remaining alcian blue staining represents
more components that contribute to the charge barrier, but heparan sulfate is specifically
important for the filtration barrier. Thus, our finding of marked decreased anionic charge
content is consistent with findings in human and experimental diabetes. Furthermore, the
decreased GBM anionic charge content with concomitant proteinuria supports the
intimate association between the charge barrier and retention of plasma proteins.
In contrast to diabetes, passive Heymann nephritis resulted in rapid and severe
proteinuria five days after injection of anti-FxlA antibody. Proteinuria peaked at one
month and persisted throughout the study. Considering this severe functional change, no
gross morphological alterations were noted in glomeruli from PHN rats after one month.
However, some capillary dilation and thickened GBM were evident after three months of
disease. Quantitation of type IV collagen, laminin, fibronectin, entactin, and anionic
charge content are scarce but consistent. The results presented here revealed profound
proteinuria at day five but no measurable changes were detected in type IV collagen,
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laminin, fibronectin, entactin, and anionic charge content in the GBM_of PHN rats during
the acute stages of this disease.
Similarly, Floege et al [109] revealed no changes in these macromolecules with
PHN.

It was shown that rats displayed marked proteinuria by day five, with no

significant alterations in glomerular morphology or GBM expansion seen during the
fifteen day period. Furthennore, gene expressions of type IV collagen, laminin B2 chain,
and S-laminin were examined and the mRNA levels for these components were
unchanged during the fifteen day study. Thus, it was concluded that the mechanisms that
lead to thickened GBM were probably different from the complement-induced
proteinuria.
Recent studies on the intrinsic glomerular epithelial cell antigen with which the

FxlA antibody cross reacts have revealed the involvement of integrin receptors. Adler
and Chen [79] demonstrated that the FxlA antibody recognizes the
specifically the

PI subunit.

a3~1

integrin,

In studies with cultured rat glomerular epithelial cells, anti-

FxlA antibody inhibited growth, spreading, and adhesion to type IV collagen, laminin
and fibronectin. Similar results were produced when using anti-PI antibody. Thus, it
was postulated that antibodies to glomerular epithelial cell antigens interfered with the
Donnal cell-GBM interaction resulting in epithelial cell effacement and retraction from
the GBM [110]. Subsequently, the altered interaction of the epithelial cell and GBM in
conjunction with the complement system resulted in proteinuria.
In summary, it was shown conclusively that these two models of kidney disease are

quite different. Diabetes affects the GBM macromolecular composition; a significant
reduction in anionic charge content correlated with significant proteinuria and significant
increases in both laminin and fibronectin that occurred in the period immediately
following proteinuria. Therefore, it is likely that the decreased negative charge content
resulted in proteinuria while the explosive increase in laminin and fibronectin were a
compensatory result to patch the damaged glomerular barrier or a pathological responce
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to proteinuria. Although overt proteinuria was evident after five

day~,

passive Heymann

nephritis had no effect on the GBM macromolecular composition: no changes in type IV
collagen, laminin, fibronectin, entactin or anionic charge content were detected. Thus,
the stimuli that lead to changes in GBM composition in diabetes are likely related to
those which result in proteinuria; however, there appears to be no relationship between
the GBM composition and overt proteinuria in PHN, or between the mechanisms for the
. induction of proteinuria in diabetes and PHN.
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Figure IV.I Method for the separation of rat glomeruli followed by isolation and
subsequent sequential extraction of the glomerular basement membranes.
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Figure IV.2 Digitized video images captured from bright field light microscopy of a
suspension of rat glomeruli purified on 75 and 63Jlm sieves. A: Low magnification. B:

high magnification. Bar = 50 JlID.

Figure IV.2
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Table IV.I Physiological parameters in control, diabetic and PHN rats measured
prior to death in groups of rats for sacrifice 1, 5, 28, 56, and 84 days after
injection.

Table IV.l

N

Day

Injection

1

CONTROL 12
DIABETIC 12
PHN
12

224.4+3.2
233.5+5.6
208.0±3.3

102.3+6.9
255.4+16.9
79.3+4.1

5

CONTROL 6
DIABETIC 6
6
PHN

249.7+4.1
225.0±5.8
234.8+4.0

68.7+2.0
175.0±25.6
73.5+10.4

28

CONTROL 12
DIABETIC 12
PHN
12

366.8+4.5
232.4+12.9
319.8+11.8

152.4+4.1
536.9+18.6
149.2+5.2

56

CONTROL 12
DIABETIC 10
PHN
10

387.6+9.9

148.2±3.2
589.4+25.4
184.2+10.6

CONTROL 12
DIABETIC 12
PHN
9

431.8+7.0
332.2+7.1
399.8+4.1

167.8+5.9
604.1+16.7
191.3+11.6

-

84

Body weight,g

Serum glucose,
mg/dl

* p < 0.05 vs control group

*
*
411.2+5.5
303.3+10.4 *
*
*

Kidney weight
Dry GBM
g/xl00g body weight mg/g Cortex

*

6.18+1.09
5.31+0.77
6.79±0.13

0.63+0.31
0.49+0.15
0.52+0.19

*

4.94+0.45
5.67+0.53
5.86+0.50

0.30+0.04
0.25+0.001
0.28+0.001

*
*
*

*
*
4.58+0.26
6.86+0.84 *
6.11+0.66 *
3.99±0.10
5.46+0.01 *
4.47+0.27 *

0.80+0.14
0.68+0.11
0.40+0.14

4.70±0.11
7.96+0.38
5.00±0.34

0.70+0.04
0.64+0.03
1.23+0.19

*

*

0.47+0.05
0.68+0.15
0.63+0.08
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Figure IV.3 Histological preparations of (A) control, (B) diabetic and (C) PHN
rat kidneys one month after injections. Tissue sections were stained with silver.
No morphological differences were apparent among the three treatments: silver
staining revealed unifonnly thin GBM and minor amounts mesangial matrix. C,
capillary lumen.
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Figure IV.4 Histological preparations of (A) control, (B) diabetic, and (C) PHN
rat kidneys three months after injections. Tissue sections were stained with silver.
No gross morphological differences were apparent between control and diabetic
glomeruli. Overall, silver staining revealed uniformly thin GBM and minor
amounts mesangial matrix with one capillary loop in diabetic glomerulus that was

dilated and possible thickened GBM. The PHN glomerulus revealed several
dilated capillary loops and silver staining indicates randomly thickened GBM
(arrowheads). Mesangial staining does not appear to be increased compared with
control. C, capillary lumen.
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. Table IV.2 Physiological parameters from control, diabetic and PHN rats
measured prior to death in rats for sacrifice one and three months after injection.
Ualb = urinary albumin excretion rate, n = 1.

Table IV.2
Day

Injection

28

Saline
Diabetic

PHN

84

Saline
Diabetic

PHN

Body weight
at injection,g

Body weight Serum glucose,
at death,g
mg/dl

Ualb.
mg/day

196
204
220

315
197
336

178
662
129

2.9
6.7
503

211
223
235

436
335
480

159
592
163

5.2
15.9
598
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Figure IV.S Urinary albumin excretion rate measured in control (open squares),
diabetic (solid squares) or passive Heymann nephritis (pHN) (open circles) rats at
1 to 84 days post-injection (6 - 12 rats per group, see table IV.!). Inserts are of
normalized volumes of urine samples from 1 to 84 days that were electrophoresed
on 10% gels and stained with silver. Immunoblotting analysis revealed that the
bands stained with silver reacted with antibodies to rat serum albumin. The fITst
detectable staining was at day 5 for the PHN rats. This staining corresponded with
the increased urinary albumin excretion in the PHN rats. This staining in the PHN
samples increased with time as did the urinary albumin excretion rate in these
rats. Both the control and diabetic samples showed staining beginning at day 28
that continued through day 84. The staining was greater for the diabetic versus
the control samples at each of these time points.
versus control.

* p< 0.05 and *** p < 0.001

Urinary albumin excretion, mg/day
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Figure IV.6 Distribution of protein in sequential extracts of GBM. GBM from
control, diabetic and PHN rats were treated sequentially with 5M guanidine (solid
bars), 5M guanidinellOmM OTI (hatched bars), and 2% SDS/DTI (stippled bars)
as described in methods. The graph indicates for each treatment the pe~centage of
protein extracted based on initial dry weight of basement membrane. Values are
means + standard error, n = 6.
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Figure IV.7 Silver stained gels of solubilized components of GBM from control,
diabetic and PHN rats. Normalized quantities (about 2 ).1g/lane) of guanidine (Gu)
extracts of GBM were electrophoresed on 6% vertical polyacrylamide slab gels in
the presence of a reducing agent. Positions of molecular weight markers are

shown to the left.
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Figure IV.8 Silver stained gels of solubilized components of GBM from control,
diabetic and PHN rats.

Normalized quantities (about 2 J.1g/lane) of

guanidine/DTT, extracts of GBM were electrophoresed on 6% vertical
polyacrylamide slab gels in the presence of a reducing agent.
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Figure IV.9 Silver stained gels of solubilized components of GBM from control,

diabetic and PHN rats. Normalized quantities (about 2 Jlg/lane) of SDSIDTT
extracts of GBM were electrophoresed on 6% vertical polyacrylamide slab gels in
the presence of a reducing agent.
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Figure IV.IO Type IV collagen in GBM extractsfrom control, diabetic and PHN

rats.

The guanidine (Gu), guanidine/DTT, and SDSIDTT extracts were

electrophoresed as in Fig. IV.7; the immunoblots were reacted with anti-type IV
collagen antibodies.

c:::

c:::

'-Io-·g-I
~
l:1
0

0

Gu

Figure IV.tO

.~.~

SDS/DTI

~

_uuo~~uo~

U

Gu/DTI

I-o·~
I .~c::: I-0 ·~- I 500
§~z
~ ~ ~~z~ ~~z 0~
~ ~ ~ 0 .~ ~ c::: o·~ ~
Cl)

U

r'\

~~

c:::

400kD205kD-

Day 1

116kD -

77kD -

400kD-

>

205kD-

Day 5

116kD -

77kD -

400kD205kD-

Day 28

116kD -

77kD -

400kD205kD-

Day 56

116kD -

77kD -

400kD205kD-

Day 84
116kD -

77kD -

i
\
i

103

Figure IV.II Laminin in GBM extracts from control, diabetic and PHN rats.
The guanidine (Gu), guanidine/DTT, and SOS/OTT extracts were
electrophoresed; the immunoblots were reacted with anti-laminin antibodies.
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Figure IV.U Fibronectin in OBM extracts from control, diabetic and PHN rats.
The guanidine (Gu), guanidine/DTT, and SDS/DTT extracts were
electrophoresed; the immunoblots were reacted with anti-fibronectin antibodies.
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Figure IV.14 A typical inhibitory EliSA (A) and testing reactivity of antibodies

to type IV collagen, laminin, fibronectin and entactin on plates coated with
laminin (B); fibronectin (C); and entactin (D). A: Typical inhibitory ELISA for
type IV collagen. Plate coated with 400 ng type IV collagen/well.

1:1000

dilution of type IV collagen antisera. This assay could detect between 1.7 to
17ng/J,l1 EHS type IV collagen. Zero protein value represents maximal binding of
antibody to antigen.

B: Type IV collagen, fibronectin and entaetin showed no

reactivity with anti-Iarninin antibodies. This assay could detect between 0.2 to

1.7ng/JlI EHS laminin; C: Type IV collagen, laminin and entactin showed no
reactivity with anti-fibronectin antibodies. This assay could detect between 20 to
200pg/J,l1 rat plasma fibronectin;

and D:

Type IV collagen, laminin and

fibronectin showed no reactivity with anti-entactin antibodies. This assay could
detect between 0.02 to 1.7ng/JlI recombinant EHS entaetin.
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Figure IV.IS Type IV collagen measured in the combined guanidine/DTT and
SDSIDTT extracts from control (open bars), diabetic (gray bars) and PHN (black

bars) OBM. Values are means + SEM, n = 8.
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Figure IV.16 Laminin measured in the combined guanidine and

orr extracts

normalized to the measured amount of type IV collagen from control (open bars),
diabetic (gray bars) and PHN (black bars) GBM. Values are means ± SEM, n = 8.

* P < 0.05 versus control.
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Figure IV.17 Fibronectin measured in the combined guanidine and DTI extracts
nonnalized to the measured amount of type IV collagen from control (open bars),
diabetic (gray bars) and PHN (black bars) OBM. Values are means + SEM, n =8.

* p < 0.05 versus control.
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Figure IV.IS Entactin measured in the combined guanidine and DTT extracts
normalized to the measured amount of type IV collagen from control (open bars),
diabetic (gray bars) and PHN (black bars) GBM. Values are means + SEM, n = 8.
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Figure IV.20 Densitometric analysis of nitrous acid treated samples. Samples
were pretreated with nitrous acid then blotted and stained as in figure IV.19.
The bar graph reflects percentage of decreased aleian blue staining values
assigned by the densitometric scanning process for control (open bars), diabetic
(gray bars), and PHN (black bars), n = 1.
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CHARACTERIZATION OF DETERGENT ISOLATED RENAL BASEMENT
MEMBRANE
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SUMMARY

Studies involving isolated glomerular basement membrane date back to 1951 when
Krakower and Greenspon localized a nephrotoxic antigen in dog kidneys [111]. Methods
for isolating glomerular basement membrane essentially have involved detergent
solubilization or ultrasonic homogenization. For the experiments in this dissertation, the
isolation methods were modified by combining them. In addition, little infonnation has
been obtained as to the purity of isolated glomerular and tubular basement membranes.
In retrospect, it was necessary to detennine if any cellular components contaminated the
isolated basement membranes and more importantly if any known basement membrane
components have been solubilized in the detergent. Examination of the deoxycholate
supernatants using SDS-PAGE revealed that the deoxycholate-soluble material was
effectively removed from mouse glomerular and tubular basement membrane and from
rat glomerular basement membrane. Immunoblot analysis indicated that type IV collagen
and lanlinin were not lost from mouse or rat GBM; however, some fibronectin was lost
during the isolation procedure. This loss is believed to represent loosely associated,
plasma fibronectin and not integral GBM fl bronec tin , however, this was not tested.
. Immunoblot analyses revealed that some type IV collagen, laminin and fibronectin were
lost from TBM during its isolation. However, the immunostaining suggested that the
losses were not significant. These results suggest that the modified isolation method for
basement membrane used here yields pure preparations of GBM; however, more
refinement of the sonication procedure is required for isolation of TBM.
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INTRODUCTION

Essentially three methodologies exist for the separation of glomeruli andlor tubules
from kidneys and, within each of the methods, variations have been used. The first
method dates back to 1951 when Krackower and Greenspon [Ill] separated glomeruli.
This method involved using a series of sieves containing differential pore sizes to first
disrupt the tissue then to trap glomeruli and/or tubules on different sieves. This is by far
the most widely used and preferred method; however, it is extremely important to tffinetune" the sieve sizes to account for the differing sizes of glomeruli in various animals.
This technique has been very successful for separating glomeruli and tubules from rat
[112,113], dog [98,114], bovine [6,115], and human [116,117].
In 1958, Cook and Pickering [118] developed an elegant method to separate
glomeruli from kidneys. This method involved perfusing kidneys with a suspension of
iron oxide after which the kidneys were homogenized in a test-tube. Only the glomeruli
trapped the iron particles, so that when a magnet was held up against the wall of the testtube, the tubule fragments could be poured off leaving behind an enriched glomerular
fraction. This method has been used successfully on rats [119,120], rabbits [118,121] and
very recently on mice [122,123].
The third method, using density gradient centrifugation, separates glomeruli and/or
tubules based on different densities. Typically the kidneys are forced through a single
sieve or homogenized to disrupt tissue prior to applying to either a discontinuous ficoll or
sucrose gradient. Since frrst introduced by Grant et al [124], other investigators have
used ficoll gradients for the separation of glomeruli from

ra~

rabbit and human kidneys

[125], the separation of tubules from rat and mouse kidneys [126-128], or the separation

.

of both glomeruli and tubules from human kidneys [129]. Successful separation of
glomeruli and tubules has also been achieved using discontinuous sucrose gradients on
mouse kidneys [88,130,131].
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To summarize, the most tried and tested method for the successful separation of
glomeruli and tubules from rat kidneys has been sieve separation. The diameter of mouse
glomeruli and tubules do not differ enough to make successful separations with sieving;
however, separation of these mouse tissues has best been accomplished using sucrose
gradient centrifugation.
Subsequent isolation of basement membrane from the glomerular and tubular
fractions has been performed using several methodologies. The common denominator
among the methods is the use of detergents and/or ultrasonic homogenization. Spiro [6]
first introduced the use of ultrasonic homogenization in combination with sieving to
isolate GBM from bovine kidneys. Later, a nondisruptive method for the isolation of
GBM and TBM was introduced by Meezan et al [132]. This method involved lysing of
cells in distilled water followed by subsequent treatment with deoxycholate (an anionic
detergent). Both of these methods, detergent and sonication, have been compared by two
separate groups. In the tITst group, isolation of GBM from rabbit glomeruli using
nonionic or anionic detergents was compared to isolation using sonication alone [130]. It
was detennined that anionic detergents were more effective than nonionic in removing
cellular material from the basement membrane, based on a lower phospholipid content in
the anionic detergent isolated basement membrane. The conclusion was that both
methods were comparable but detergent yielded a more intact basement membrane. The
second group made a similar comparison of detergent-treated versus sonication-treated
methods for the isolation of GBM [133]. They detennined that the methods were overall
similar yet had some differences.

Electrophoresis revealed similar heterogeneous

polypeptide patterns between the two methods; however, detergent treatment yielded
more enriched collagen-typical amino acids, while sonication treatment yielded higher
concentrations of sulfated glycosaminoglycans. It was concluded that the two methods
were comparable, yet warned that these methods would also result in the disruption or
removal of certain constituents of the basement membrane.
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In most of these studies described thus far, investigators were concerned about the
purity of the isolated basement membrane. That is, they asked the question" had the

cellular material been effectively removed during either detergent or sonication isolation
of basement membrane? Both methods were shown to have effectively removed cellular
contamination from the isolated basement membrane, as assessed by low levels of
cellular markers such as DNA, RNA, and phospholipid phosphorous [6,130,133].
Although these isolation methods appear to be effective at removing cellular
contamination, the specific loss of integral basement membrane components was never
explored. In any compositjonal analysis of isolated basement membrane, it is imperative
to know if loss of basement membrane components has occurred. In retrospect, we were
curious as to the efficacy of our method for the isolation of GBM and TBM from mouse
kidneys as well as GBM from rat kidneys. Specifically, were any known glomerular
basement membrane components solubilized with the detergent? We assessed the purity
of the isolated glomerular and tubular basement membranes using gel electrophoresis and
immunoblots probing specifically for loss of collagen IV, laminin, fibronectin and
entactin.
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MATERIALS AND METHODS

Isolation of mouse GBM and TBM. Mouse glomeruli and tubules were separated
using sucrose gradient centrifugation followed by subsequent sonication of these tissues
in the presence of deoxycholate to isolate GBM and TBM as described in chapter three.

Isolation of rat GBM. Rat glomeruli were separated using differential sieving
followed by subsequent sonication of this tissue in the presence of deoxycholate to isolate

GBM as described in chapter four.
Analysis of detergent supernatants. SDS polyacrylamide gel electrophoresis was
perfonned using vertical slab gels [89]. Samples were electrophoresed on 6% gels with
an overlying 4% stacking gel. Proteins were visualized by silver or transferred to a
nitrocellulose membrane (Schleicher & Schuell) and immunoblot analysis was perfonned

[90] as described in chapter three.
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RESULTS
Isolation of mouse GBM and TBM. Given that compositional differences were
determined (chapter UI), it was important to determine if GBM and TBM had isolated
similarly. To verify that removal of cellular material occurred without loss of basement
membrane , samples of the consecutive deoxycholate supernatants from both glomeruli
and tubules were run out on gels, and either stained with silver (Fig. V.I) or transferred to
nitrocellulose and probed with anti-type IV collagen (Fig. V.2A) anti-Iaminin (Fig.. V.2B)
and anti-fibronectin (Fig. V.2C). Figure V.l shows that most of the deoxycholate-soluble
material was removed from the glomerular and tubular fractions with the frrst sonication,
with only a few bands remaining in the third glomerular supernatant. However, in the
tubules, the third deoxycholate supernatant showed an increase in solubilized material.
Figure V.2A shows staining for type IV collagen in the third supernatant for tubules.
The immunoblot of the deoxycholate supernatants probed with anti-Iaminin antibody
(Fig. V.2B) showed no detectable staining in the supernatants from glomeruli; however,
faint staining in the frrst and third supernatants from tubules was observed. Figure V.2C
shows significant staining for fibronectin in all three deoxycholate supernatants from both
glomeruli and tubules.

Isolation of rat GBM. To assess differences in the diseased OBMs, it was necessary
to determine if the two diseased GBMs isolated similarly . To verify that removal of
cellular material occurred, samples of the consecutive deoxycholate supernatants from
glomeruli of control, diabetic and PHN rats were run out on gels and stained with silver
(Fig. V.3). Figure V.3 shows that all the deoxycholate-soluble material was removed
from the glomerular fractions of control, diabetic, and PHN rats by the fIrst sonication.
As there were no differences in the staining patterns for these samples from days 1 to 84,
figure V.3 is a representative silver-stained gel containing day 28 samples. To evaluate
the loss of known GBM components during its isolation, samples of the consecutive
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deoxycholate supernatants from glomeruli of control, diabetic and PHN rats were run out
on gels, transferred to nitrocellulose and probed with anti-type IV collagen (Fig. V.4A)
anti-Iaminin (Fig . V.4B), anti-fibronectin (Fig. V . 4C), and anti-entactin (Fig. V.4D).
Each of these figures is a representative immunoblot containing samples from day 56.
The immunoblots for type IV collagen, laminin and entactin revealed no staining for
these macromolecules; however, the immunoblot for fibronectin revealed equally strong
staining among the first and second deoxycholate supernatants from the glomeruli of
control, diabetic, and PHN rats.

131
DISCUSSION

Extensive preliminary tests separating mouse glomeruli and tubules using ficoll and
percoll gradient centrifugation with prior disruption of tissue using various sieve sizes
proved to be very unsatisfactory (data not shown). The method of using sucrose
gradients proved to be very successful in separating pure fractions of glomeruli and
tubules from the same mouse kidney; therefore, we chose to exploit this method [88].
The separation of glomeruli from rat kidneys is commonly performed using the
differential sieving; therefore., we used this method for the separation of glomeruli from
control, diabetic, and PHN rats. For the isolation of mouse GBM and TBM and rat
GBM, we modified the detergent method of Meezan [132] and the sonication method of
Spiro [6] resulting in a combination of the two. To our knowledge this is the frrst time
sonication in the presence of deoxycholate has been used for the isolation of basement
membrane.. Because of this it was necessary to evaluate the effects of volume of
deoxycholate and length of sonication on equal weights of isolated glomeruli. We
concluded that the volume of deoxycholate should be normalized to 1m! per 50mg wet
tissue weight and that the sonication times also needed to be standardized to 1 minute per
3ml deoxycholate volume.

Isolation o/mouse GBM and TBM. For the present study, we assessed the purity of
isolated mouse GBM and TBM using SDS-PAGE andimmunoblots probing specifically
for loss of type IV collagen, laminin and fibronectin from the isolated basement
membranes..

The results, based. . ·on electrophoretic profiles, demonstrated that the

deoxycholate-soluble material was removed from the basement membranes. hnmunoblot
analysis., however, showed that some type IV collagen and Iaminin were lost from TBM
during sonication while some fibronectin was lost from both GBM and TBM. When pure
tubular fractions were viewed by light microscopy, it was noted that a large number of
tubule fragments were free of attached cells--exposed tubular basement membrane-
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whereas, glomerular fractions appeared to be intact structures with attached cells. Thus,
the effects of the sonication treatments on the two tissue fractions may have been
different, such that GBM was not initially as vulnerable to the sonication treatment as
was TBM. The laminin lost during the isolation of TBM indicates that the difference in
the amount of laminin (described in chapter three) would have been even greater between
GBM and TBM. The difference in the amount of fibronectin we reported as compared to
Mohan and Spiro [15] may be due to the loss of fibronectin during the modified isolation
oftheGBM.

Isolation of rat GBM.. Although the earlier results on the isolation of mouse GBM
indicated that type IV collagen and laminin were not significantly lost during isolation,
some fibronectin was lost during the deoxycholate and sonication procedures. Thus, it
was necessary to detennine if GBM from control, diabetic and PHN rats had isolated
similarly. The assessment of deoxycholate-sonication isolated rat glomerular baselnent
membrane with type IV collagen, laminin and fibronectin was also extended to
incorporate entactin. The results indicate that all the deoxycholate soluble material was
removed from the GBMs.

This is presumably an indicator of lack of cellular

contamination. However, what this will not reveal is if some fragments of cytoskeletal
elements or DNA are present in the isolated GBM. Type IV collagen, laminin and
fibronectin were not lost from the GBM; however, some fibronectin was lost during the
isolation procedure. The staining for fibronectin appeared to be of the same intensity
among the control, diabetic and PHN GBMs. In addition, the staining was only detected
in the fIrst and second deoxycho}.ate supernatant with the second supernatant revealing
diminished staining.

This suggests that this staining represented a more loosely

associated or trapped fibronectin and that the fibronectin measured in GBM that required
reducing conditions for extraction was of local origin.

The deoxycholate-soluble

fibronectin may actually represent serum fibronectin trapped during glomerular filtration,
but this was not tested.
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In summary, the modified method of basement membrane is<?lation used in this
study yields pure preparations of GBM from both mice and rats. In the isolated TBM
from mice, there is some loss of TBM components, although apparently not significant.
These losses in TBM might be a result of greater vulnerability to sonication used in its
isolation. The architectural geometry of glomeruli and tubules is quite different. The
glomerulus is composed of highly coiled compact loops of capillaries that are ensheathed
by the epithelial podocytes. The foot processes of the podocytes are highly interdigitated
and anchored in numerous sites to the GBM through integrins. The endothelial and
mesangial cells are also anchored to the GBM or mesangial matrix. Thus, this tightly
associated arrangement of glomerular cell types results in a structure that may require
thorough sonication. The tubule fraction is made up of different size fragments, however
short, that are presumably open ended tubes. Each tubule fragment is composed of a
single layer of epithelial cells anchored to the underlying TBM. In contrast to the GBM,
the TBM has only one cell layer attached to it leaving the other side directly exposed to
the first sonication. Thus, the tubular fraction may not have required as extensive
sonication as the glomerular fraction.
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Figure V.I Assessment of the removal of deoxycholate-soluble protein from
isolated mouse glomeruli and tubules by electrophoresis. Tissue was sonicated in

the presence of 1% deoxycholate and centrifuged; this was carried out a total of
three times.

Normalized volumes of the three subsequent deoxycholate

supernatants from both glomeruli and tubules were electrophoresed, and then
silver-stained. Lanes 1 to 3 illustrate consecutive 1% deoxycholate supernatants
from either glomeruli or tubules.
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Positions of molecular weight markers,

Glomeruli
I1 2 3 I

Tubules
I 1 2 3

205kD116kD66kD-

45kD- ,

Figure V.I

I

136

Figure V.2 Assessment of the removal of deoxycholate-soluble protein from
isolated mouse glomeruli and tubules by immunoblotting. Nonnalized volumes of
the three subsequent deoxycholate supernatants from both glomeruli and tubules
were electrophorese<L transferred to nitrocellulose and immunoblotted with anticollagen IV (A), anti-Iaminin (B) and anti-fibronectin (C) antibodies. Lanes 1 to
3 show consecutive 1% deoxycholate supernatants from either glomeruli or
tubules. elY, type IV collagen, lOflg; LM,laminin, Iflg; FN, fibronectin, IJlg.
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Figure V.3 Assessment of the removal of deoxycholate-soluble protein from
isolated rat glomeruli by electrophoresis. Normalized volumes of the three
subsequent deoxycholate

supe~atants

from glomeruli were electrophoresed, and

then silver-stained. Lanes 1 to 3 show consecutive 1% deoxycholate supernatants
from glomeruli of either control, diabetic or PHN rats.
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Figure V.3
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Figure V.4 Assessment of the removal of deoxycholate-soluble protein from
isolated rat glomeruli by immunoblotting. Normalized volumes of the three

subsequent deoxycholate supernatants from glomeruli were electrophoresed,
transferred to nitrocellulose and immunoblotted with anti-collagen IV (A), antilaminin (B), anti-fibronectin (C), and anti-entactin (D) antibodies. Lanes 1 to 3
show consecutive 1% deoxycholate supernatants from glomeruli of either control,
diabetic or PHN rats. CIV, type IV collagen, l0J.1g; LM, laminin, IJ.1g; FN,
fibronectin, IJ.1g; EN, entactin, IJlg.
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A HETEROGENEITY OF GLOMERULAR AND TUBULAR BASEMENT
MEMBRANES.

Historically, the discovery of the EHS tumor (1980) was a turning point in
elucidating the composition of extracellular matrices, specifically basement membranes.
This tumor was shown to synthesize large amounts of basement membrane-like matrices
and was readily grown in mass quantities in the hind legs of mice. Therefore, sufficient
quantities of pure basement membrane were obtainable.

Unlike native basement

membrane, the EHS tumor was effectively solubilized using differential salt extractions.
From these extracts, specific components were isolated and characterized using
biochemical and immunological methods. Prior to the EHS tumor, studies on basement
membrane composition were limited to chemical analyses.

These analyses were

conducted on glomerular basement membrane; however, the quantity of isolated GBM
was limited and insoluble to conventional extraction procedures. Despite that specific
constituents of basement membrane were not known, these chemical analyses were
groundbreaking for proposing heterogeneity of basement membrane composition.
Carbohydrate analyses revealed heterogeneity regarding sugar composition. It was
concluded that GBM and TBM contained the same monosaccharides but differed in
relative amounts: GBM contained a greater amount of sialic acid residues than TBM
[134]. This suggested that the GBM contained a greater negative charge content than
TBM.
L,angeveld and coworkers made comparisons of glomerular and tubular basement
membranes from different animals:

cattle, pig, sheep, horse, and rat [135,136].

Conducted on the basis of amino acid composition, their studies detected differences in
amounts of hydroxylated amino acids. This suggested heterogeneity of collagen content
as hydroxylated amino acids are unique to collagen. These studies were extended to
include comparisons of human glomerular and tubular basement membrane. It was
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demonstrated that, regardless of age in men, the GBM contained more 3-hydroxyproline,
mannose, and sialic acid residues than did the TBM [117,129,137].
In contrast, Butkowski and De demonstrated that the amino acid compositions of

mouse GBM and TBM were very similar [131]. It was also demonstrated that the mouse
OBM was similar to that of other species and that the chemical composition of mouse
TBM was essentially identical to rabbit.

Additionally, Brendel et al compared

electrophoretic chromatographs of solubilized OBM and TBM from rabbits [121]. It was
reported that there were no significant differences between the two basement membranes.
As was demonstrated in chapter three, comparisons of electrophoretic

chromatographs did reveal subtleties but not striking differences between mouse OBM
and TBM despite the presence of significant quantitative differences in compositions.

Thus, the results reported by Brendel et al were inconclusive [121]. The mouse kidneys
used by Butkowski and De were from mixed strains and not age-matched. Because of the
nonhomogeneous tissue donors, one cannot preclude that differences between mouse
GBM and TBM may have been diluted. Furthermore, evidence exists for effects of age
on basement membrane composition. The content of hydroxylated amino acids namely,
lysine and proline, increased with age in normal rats [138]. Thus, mixing of tissue from
different ages would make accurate comparisons difficult
More evidence for heterogeneity of glomerular and tubular basement membranes
resulted from immunohistochemical studies. Using specific antibodies against EHS
components, differences in labeling patterns in GBM and TBM were seen. The
noncollagenous glycoproteins, laminin and fibronectin, were immunolocalized in mouse
and rat kidneys [94,139]. It was revealed that laminin was uniformly distributed
throughout TBM, mesangial matrix and Bowman's capsule in both mouse and rat
kidneys. In the GBM, laminin was restricted to the lamina rara interna. However,
contradictory results were reported for the distributions of fibronectin in mouse and rat
kidneys. In the mouse, fibronectin was present only in mesangial matrix.

In the rat,
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fibronectin was abundant in the mesangial matrix, but it was also detected in the lamina
rarae of the GBM, Bowman's capsule and to a lesser extent in the TBM. Thus, these
results not only suggested heterogeneous compositions among basement membranes, but
also between animal species. With this in mind it was of interest to compare the mouse
and rat GBMs described separately in this dissertation to further explore this issue of
basement membrane heterogeneity between species.
Identical amounts of lyophilized mouse and rat GBM were used, and the extraction
procedures and volumes were identical. In comparing the extraction procedures of the
two GBMs, total protein measurements revealed that 30% of mouse and 50% of rat GBM
were extracted. This suggested an incomplete solubilization of the GBMs. However,
visually comparing the GBMs before and after the extractions, it was demonstrable that
the majority of the pellets were extracted leaving a small insoluble pellet. Protein assays
can be very accurate in measuring individual protein solutions provided the appropriate
standards are used. However, these assays are clearly inadequate to precisely measure a
complex mixture of proteins.

Due to the large diversity of the macromolecular

composition of the GBM, the protein standard, bovine serum albumin, cannot accurately
represent these macromolecules. Unfortunately, there is no one protein that can do this.
Therefore, results based solely on protein assays must be used with caution and should be
used for relative measurements.
Comparing electrophoretic protein profIles from the mouse (Fig. m.S) and rat (Figs.
IV.7, IV.8, & IV.9) GBM extracts revealed an overall similarity with subtle differences.
The guanidine extracts revealed numerous bands ranging from 400 kD down to the dye
front (45 leD) in both animals. The extracts with DTf revealed fewer small molecular
weight bands in mouse GBM compared to rat OBM. The significance of this is
unknown. The SDS extracts from mouse and rat GBM revealed remarkable similarities:
strong staining bands that migrated alongside the alpha chains of type IV collagen.
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Immunoblotting revealed the presence of laminin and fibronectin exclusively in the
guanidine and DIT extracts in both mouse and rat GBM. In the case of laminin, the B
chains were detected in these extracts of mouse and rat OBM. However, the A chain was
not detectable in either mouse or rat GBM. This absence of staining was believed to be
due to undetectable amounts of A chain or that an undiscovered isofonn of laminin A
chain was present in GBM.
Quantitation of total extracted laminin revealed a large difference in the content
between mouse and rat GBM: mouse GBM contained 2.6 times less laminin compared to
rat OBM (1.8 J,1g vs 4.6 Ilg/mg, respectively). Quantitation of fibronectin revealed
similar amounts in mouse and rat OBM, 8.2 J.1g vs 7.2 J,1g/mg, respectively. Mouse and
rat OBMs appear to share similar compositions, but have significant differences in
relative amounts. Thus, these differences suggest heterogeneity among the GBMs of
these two rodents.
More substantial evidence for macromolecular heterogeneity of glomerular and
tubular basement membrane resulted from the discovery of isofonns of laminin, and type
IV collagen. An isofonn of laminin demonstrated a heterogeneous distribution among
renal basement membranes. The recently described S-laminin or laminin Bls was
detected in rat, rabbit and human OBM, but not TBM [32,33,140]. Similarly, two
isoforms of type N collagen were recently identified as described in chapter two. These
novel chains of type N collagen [a3(N) and a4(IV)] were localized only to the lamina
densa and lamina rara extema of the GBM [33,141-143]. A greater distribution of the
classical chains of type IV collagen has been shown. These classical chains of type IV
collagen [al(N) and a2(IV)] were localized to the lamina rara interna (subendothelial
aspect), mesangial matrix, and all tubular basement membranes in human kidneys [141143]. The recently described a5(IV) chain of type IV collagen was shown to be
restricted to the OBM by immunostaining [144].

j
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While immunocytochemistry is the ideal technique for localization of specific
basement membrane components, this technique does not permit determination of
absolute concentrations of various components of basement membranes. The assessment
of known as well as unknown components requires solubilization of the basement
membrane.
Mohan and Spiro [15], were the only investigators to report amounts of solubilized
OBM components, but not for TBM. The results described in this dissertation are the
only reported amounts for solubilized components of GBM and TBM from the same
kidney.

Using these tissues from the same kidneys and isolated under identical

conditions, thus allowed for precise comparisons of the two basement membranes.
Compositional heterogeneity was clearly demonstrated between mouse GBM and TBM
as previously described (chapter three).

Along with qualitative differences in

electrophoretic protein profiles, the total amount of laminin measured in the GBM was
half that of TBM.

From the studies described above, it was apparent that glomerular and tubular
basement membranes shared similar components; however, the amounts varied. On the
basis of this heterogeneity in basement membrane composition, it was postulated that
concentration differences in various components would result in heterogeneity of
structure and function [10,145]. If this postulate was true, then the glomerular and
tubular basement membranes should have different functions. Currently, this cannot be
answered because the functional significance of the TBM has not been defmed. The
major function of the GBM has been shown to be a highly selective permeable barrier;
however, the understanding of the mechanisms of this barrier is in its infancy. Although,
sulfated glycosaminoglycans have a role in the charge selectivity in GBM, the
physiological relevance, if any, of other basement membrane components has yet to be
determined. In other words, do individual constituents impart penneability properties to
the GBM? It is more likely that this property of the GBM is due to the sum and not
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necessarily the individual parts. Electron microscopy studies have revealed that the GBM
is composed of a backbone of type IV collagen to which other components attach [7].
These cords fonn a highly compact three dimensional meshwork that presumably imparts
the size and charge restrictive properties.
distributed throughout the GBM;

This implies that the components are

however, immunohistochemistry studies have

demonstrated that the components are not uniformly distributed [14]. On the basis of on
this, perhaps the cords vary in macromolecular composition, resulting in a composite
structure with distinct regions or local environments. Evidence for distinct regions in the
GBM exists for heparan sulfate proteoglycan. This proteoglycan was localized to the
lamina rara interna in apposition to the lamina dens a [146]. In this position, it is likely
that the sulfated glycosaminoglycans generate a negatively charged shield retarding
filtration of macromolecules by both electrostatic repulsion and sterlc hindrance.

B EFFECTS OF DIABETES ON GLOMERULAR BASEMENT MEMBRANE
COMPOSITION.

It is generally known that in diabetes mellitus and passive Heymann nephritis,
damage to the glomerular barrier occurs and is accompanied by an increase in
penneability to proteins the size of albumin and larger. While the pathogenesis of
proteinuria has not been established, alterations in the charge as well as the size barrier of
the glomerular basement membrane have been suggested [64,147]. Furthennore, changes
in the macromolecular composition of glomerular basement membrane have been
implicated in proteinuria in both diabetes and passive Heymann nephritis [13,95]. The
macromolecular alterations in these two diseases will be discussed separately in the next
two sections.
Insulin-dependent diabetes mellitus is characterized by progressive GBM thickening
and proteinuria in later stages. Alterations in type IV collagen have been implicated in
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the progressive thickening of diabetic OBM. An increase in type N. collagen in diabetic
kidneys was originally based on measuring amounts of hydroxylated amino acids, namely
hydroxylysine and hydroxyproline [148]. Hydroxyproline is unique to collagens and type
IV collagen contains a higher percentage of both hydroxylysine and hydroxyproline than
any of the fibrillar collagens. Thus, measurements of these two hydroxylated amino acids
can provide a relative index of type IV collagen content [68,69]. Even though the amount
of these hydroxylated amino acids is greater in type IV collagen, the presence of fibrillar
collagens containing lesser amounts of these amino acids would have a diluting effect,
resulting in a decreased content of these amino acids. Thus, the method of tissue
isolation and preparation becomes increasingly clear as to the importance of obtaining
reproducible pure GBM samples. The results based on these hydroxylated amino acids
have been disparate.
In 1970, Beisswenger and Spiro [148] first demonstrated a significant increase in

the amount of hydroxylysine content in human diabetic OBM. Later they added a
significant increase in the amount of hydroxyproline to their results on human diabetic
GBM [68]. Similarly, Klein et al [69] showed that human diabetic glomeruli were larger,
heavier and contained a greater amount of hydroxyproline than nondiabetic glomeruli.
In contras~ three separate investigations demonstrated no significant changes in the
amounts of these hydroxylated amino acids in human diabetic glomeruli [70-72].
Although the data were not statistically significant, there was an increase over control in
these three investigations.

It was noted when reviewing the data from these

investigations that in all cases the kidneys were from cadavers that had varying durations
of diagnosed diabetes ranging from 1 to 31 years. Furthermore, only some of the patients
exhibited non-insulin dependent diabetes mellitus. Because of this non-homogeneous
tissue, the severity of diabetic states was quite different in these patients. Since diabetes
mellitus is a slow progressive disease involving glomerulosclerosis ultimately leading to
renal failure, it is not surprising that conflicting results were obtained in these studies.
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In an attempt to explain the disparity in these results, some of the investigations
mentioned above will be reviewed as follows. The investigations by Klein et al [69]
attempted a time course study measuring the levels of hydroxyproline in human diabetic
glomeruli. The time course covered ten patients with durations of diagnosed diabetes
ranging from 1 to 31 years. Of the ten patients only three were of insulin-dependent
diabetes, and the duration of diabetes in these three ranged from 13 to 31 years. They
found that in the 1 to 6 year range of diabetes, glomeruli showed no change in amounts of
hydroxyproline. From the 7 to 31 year duration of diabetes, glomeruli showed significant
increases in hydroxyproline. Interestingly, the increases were fairly constant, 39±2.2%
(mean + SEM), considering the extreme differences in duration of diabetes, type and
severity of disease. Similarly, results reported by Beisswenger and Spiro [68] showed
that the increased hydroxylysine content in diabetic glomeruli appeared to be fairly
constant, 15.4±2.5% (mean + SEM), over 6 to 26 year durations of diabetes.
The lack of statistically significant increases in hydroxylated amino acids reported in
the conflicting studies could be explained on the basis of tissue isolation techniques.
Crude preparations of glomeruli were isolated at best using only an initial tissuedisruption sieving step as opposed to more refined sieving procedures used by Spiro and
colleagues. Thus, the overall discrepancies in type IV collagen content of diabetic
glomeruli may be a result of techniques of basement membrane preparation and using
nonhomogeneous diabetic tissue, i.e., kidneys differing in" duration of diabetic state
and/or type of diabetes. Basement membrane preparations may be contaminated with
interstitial collagens, which contain the same bydroxylated amino acids, thus an estimate
of type IV collagen content based on these modified amino acids can not be considered
optimal.
The generation of antibodies to type IV collagen led to immunohistochemical studies
revealing alterations in the distribution of type IV collagen in diabetic kidneys.
Antibodies to Cll(IV) and a2(IV) chains of type IV collagen revealed increased staining
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in GBM [95,96,105,149,150] of rats with a duration of diabetes ranging from 7 to 12
months. However, staining of mesangial matrix revealed conflicting results for these two
alpha chains of type IV collagen; Desjardins et al [95] showed no change in mesangial
staining at 12 months of streptozotocin diabetes while Abrass et al [107] demonstrated a
three-fold increase in staining after 6 weeks of streptozotocin diabetes.
In two separate studies, heterogeneous staining for type IV collagen during
progressive stages of diabetes in humans was revealed [96,105]. It was shown that in
patients with "mild to moderate" diabetes (nonnal renal function to urinary protein
excretion < 300 mg prot/day; varying degrees of thickened basement membrane and
mesangial expansion) showed increased staining for type IV collagen in GBM and
mesangial matrix [96,105]. However, when they examined GBM and mesangial matrix
in patients termed "severe" (renal insufficiency, urinary protein excretion> 2.5 g
prot/day, severe glomerular sclerosis and mesangial expansion) there was a significant
decrease in staining compared with control tissue [96,105].
All of these studies described thus far have reflected long-tenn effects of diabetes on
glomeruli from both human and experimental animals. Typically, these studies used
tissue whereby morphological (thickened GBM and expanded mesangial matrix) and
functional (decreased renal function and measurable proteinuria) changes were clearly
established. Very few studies have been performed looking at the acute effects of
diabetes on type IV collagen .content in glomeruli. They are summarized as follows.
Ayo et al [106] demonstrated that mesangial cells cultured one week in high glucose
concentration synthesized and secreted greater amounts of type IV collagen compared to
mesangial cells grown in normal glucose concentrations. Similarly, Haneda et al [151]
showed a significant increase in amount of secreted type IV collagen from mesangial
cells cultured in high glucose concentration for 4, 6, 8 and 12 days. In an acute study
with spontaneously diabetic KKAy mice, Ledbetter et al [101] measured the mRNA
levels of a1(IV) and a2(IV) chains of type IV collagen in the cortices at 1, 2, 4 and 6
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months of diabetes. No differences in mRNA levels were detected at 1 and 2 months
while a two-fold increase was detectable at 4 months and continued to increase four-fold
by 6 months. Recently, Ihm et al [102] using isolated glomeruli from streptozotocin
diabetic rats detected no changes in glomerular al(IV) mRNA levels at 1 week or 1
month. Thus, acute studies with cultured mesangial cells revealed a rapid induction of
type IV collagen synthesis and secretion, whereas, whole animal studies reflected a much

slower induction of type IV collagen synthesis. In the acute assessment of GBM
composition described in chapter four, neither time nor disease affected the measured
amount of type IV collagen. Thus, collectively these data indicate a lack of change in the
amount of type IV collagen during the onset of experimental diabetes, therefore
suggesting a delayed induction of type IV collagen synthesis.
To summarize this account of type IV collagen in diabetes, amino acid analyses
revealed a significant increase, albeit small, in type IV collagen content. Results from
immunostaining revealed more substantially an increased staining for type IV collagen in
diabetic GBM.

Finally, results from cultured mesangial cells and whole animals

demonstrated increased synthesis of type IV collagen. Taken together, these results
demonstrate conclusively an increased amount of type IV collagen in the glomerular
matrix of dia~tic lddneys. The specificity of this summary lies not so much in the
uniqueness of increased type IV collagen, but rather in the time frame in which the
increases were detectable. Perhaps. alterations in the GBM composition may be divided
into distinct and progressive stages.
Alterations in other GBM macromolecules have been implicated in insulin
dependent diabetes mellitus. The laminin content of the GBM has been examined in
experimental and human diabetes; however, results are disparate. Initial studies on
laminin content revealed an increased amount in diabetes. Rohrbach et al grew EHS
tumors in nonnal and genetically diabetic mice [73]. After three weeks, tumors were
harvested and laminin was quantitated using inhibitory ELISA. It was demonstrated that
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the tumors grown in diabetic mice had almost twice the laminin cpntent compared to

tumors grown in nondiabetic mice. The relevance of ~s result is inconclusive due to the
biological difference between the mature GBM of the glomerulus and the basement
membrane-like matrix of the implanted tumor.
The generation of antibodies to EHS laminin led to immunohistochemical studies
that revealed alterations in the staining of laminin in diabetic kidneys.

Falk et al

examined the staining intensity of laminin in the GBM and mesangial matrix in two
different stages of human diabetes [96]. In both GBM and mesangium, significant
increases in laminin content were detected in early stages (patients presented with
proteinuria, <300 mg/Day, varying degrees of GBM thickening and mesangial expansion)
while significant decreases in laminin content were observed in severe stages (patients
presented with proteinuria, >2.5g/day, thickened GBM, glomerulosclerosis and severe
mesangial expansion). Similarly, Nerlich et al demonstrated with antibodies to laminin
that significant increases in laminin staining were detected in early stages of diffuse
glomerulosclerosis in diabetic kidneys and subsequent decreases in laminin staining in
the late severe stages of nodular glomerulosclerosis [105].
U sing a radioimmunoassay, Shimomura and Spiro quantitated the amount of laminin
in the GBM of diabetic kidneys taken at autopsy [12]. It was demonstrated that a 40%
decrease in laminin was measured in diabetic kidneys compared with normal, 0.85 J,1g/mg
GBM and 1.4 J.1g/mg GBM, respectively.

Thus, these results taken with the

immunohistochemistry data indicate that changes in laminin content may be divided into
distinct stages during the progression of diabetes mellitus as was apparent for type IV
collagen.
An increased amount of laminin content in the early stages reflected either an
increased synthesis of laminin mRNA and translation or decreased degradation and
removal from the GBM. Ledbetter et al [101] measured the levels of laminin Bl chain
mRNA in cortex from genetically diabetic mice after 1, 2, 3, and 5 months. They showed
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no change in the mRNA levels during the acute stages of diabetes, even with evident
proteinuria at one month. Giambrone and Brownlee [74] measured the levels of laminin
B 1 chain mRNA in whole kidneys from streptozotocin diabetic rats after seven and ten
months of disease. A three-fold increase in the level of laminin B 1 chain mRNA was
demonstrable in these diabetic kidneys. It is difficult to extrapolate these mRNA results
to the cells of the glomerulus. Unfortunately, no studies have measured the mRNA levels
for laminin in isolated glomeruli. However, mRNA levels have been measured in
cultured mesangial cells grown in high glucose concentrations after one week [106]. It
was demonstrated that a 40 - 50 % increase in mRNA levels for laminin occurred after
one week; furthermore, a 50 - 60 % increase in the amount of laminin was measured
after one month in these cultured mesangial cells.
In the acute assessment of GBM composition described in chapter four, laminin was

significantly increased at day five and continued to increase through three months. Thus,
collectively these data indicate an increased synthesis and amount of laminin during the
onset of diabetes followed by a decrease in amount during the latter severe stages of the
disease.
Immunohistochemical studies of fibronectin revealed significant increases in
staining during the early and moderate stages of human diabetes with subsequent
decreases in the latter severe stages of the disease [96,105].

In these two

immunohistochemical studies, the increased fibronectin staining was more pronounced in
the mesangial matrix as compared to the GBM.

Similarly, Abrass et al [107]

demonstrated a significant increase in fibronectin staining in mesangial matrix in
streptozotocin diabetic rats after six weeks.
The effects of high glucose concentration on fibronectin synthesis in mesangial
cells were examined. Cultured mesangial cells were grown one [106] and two weeks
[152] in high glucose concentrations. It was demonstrated that both the amounts of
fibronectin and mRNA levels were significantly increased in these cultured cells.
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In the acute assessment ofGBM composition described in chapt~r four, quantitation

of fibronectin revealed a significant increase at two months and persisted through three
months. Shimomura and Spiro quantitated the amount of fibronectin from severely
diabetic kidneys taken from autopsy and showed that there was no change in the amount
of fibronectin in the latter severe stages of diabetes (diabetic, 2.9 J.lg/mg vs non diabetic,
2.2 J.lg/mg GBM) [12].
Collectively these results for fibronectin indicated increased synthesis of fibronectin
during the onset of diabetes with subsequent decreased amounts during the latter severe
stages of the disease. Thus, suggesting a similarly altered differential expression during
the progression of diabetes as was observed for laminin.
Examination of entactin in diabetic kidneys was, until now, limited to
immunostaining. Immunohistochemical studies revealed in early stages of diabetes
prominent entactin staining in mesangium where mesangial expansion was present [108].
This mesangial staining disappeared with progression of the disease; however, thickened
GBM showed an increased entactin staining. Amounts of entactin have not been
measured in diabetic GBM. In the acute assessment ofGBM composition described in
chapter four, quantitation of entactin revealed no effects of disease or time. Thus, in
conjunction with immunohistochemical studies, entactin does not appear to be altered
during acute stages, but may be affected with progression of diabetes.
In the studies described thus far for type IV collagen, laminin, fibronectin and
entactin, it was never precisely determined when alterations in these components
occurred with reference to proteinuria.

To determine if alterations in these

macromolecules may be involved in the pathogenesis of diabetes or if alterations are a
consequence of increased filtration, it is necessary to establish the differential alterations
of these components during induction of the disease.
The results in chapter four revealed that proteinuria in the streptozotocin diabetic
rats was evident by day 28 and persisted through day 84. No changes in the amounts of
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type IV collagen or entactin were measured in these diabetic rats; however, significant

increases in both laminin and fibronectin were detected on days 5 and 56, respectively.
The increase in laminin content over control preceded the onset of proteinuria, yet a more
profound increase in laminin content occurred between days 28 and 56 at the time
immediately after the onset of proteinuria. These differential increases in laminin content
suggested that diabetes resulted in an initial increase that was subsequently exacerbated
by the presence of proteinuria.
The increase in fibronectin content over control was not apparent until after
proteinuria had begun. However, this increase was profound and occurred, like laminin,
during the interval immediately following the onset of proteinuria.

Whether

hyperglycemia had direct effects on laminin and fibronectin synthesis or that the
increases were compensatory to restore normal fIltration are unknown.
Recent studies have suggested an important role for the nonenzymatic glycation of
various glomerular basement membrane proteins in contributing to the altered structure
and function of the GBM in diabetes [153].

The metabolic consequence of

hyperglycemia could be an important contributory feature to tissue damage in diabetes.
Nonenzymatic glycation refers to the condensation reaction between glucose and free
amino acids at the amino terminus of lysine residues of proteins [154]. GBM proteins
such as type IV collagen are rich in lysine and hydroxylysine, have a long tissue half-life,
and are continuously exposed to ambient levels of glucose in the blood [155]. Studies
now demonstrate that there is a two- to three-fold increase in the level of glycation of
collagens from tissues of diabetic subjects or animals compared to controls [155].
The effects of these glycations have included resistance to collagenase digestion
and interference with normal cross-link fonnation [153], and changes in various physical
properties of the molecules such as thennal stability and tensile strength [156]. Finally,
the nonenzymatic glycation of noncollagenous GBM proteins that act as adhesion
molecules, such as laminin [157], fibronectin [158], and heparan sulfate proteoglycan
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[159], and thereby influence assembly and electrical charge of the basement membrane,
may also have important functional consequences [160]. Loss of charge may ultimately
contribute to proteinuria.
Kanwar showed that a reduction in one of the anionic constituents of GBM
(heparan sulfate proteoglycan), resulted in altered charge-permselectivity of the GBM
with subsequent proteinuria [65]. Thus, the physiological relevance of the anionic charge
barrier with the normal filtration properties of the GBM was demonstrated. However, it
was not known to what extent a reduction in total heparan sulfate proteoglycan or
alterations in individual heparan sulfate chains had on proteinuria in diabetes.
Metabolic studies measuring the incorporation of 35S-sulfate in streptozotocin
diabetic rats demonstrated a significant decrease in total glomerular glycosaminoglycans
after 17 days of diabetes [161-163]. Studies were extended to include measurements of
heparan sulfate in diabetic rats and humans [76,77].

These studies demonstrated

significant reductions in heparan sulfate content of diabetic GBM. Further analyses
revealed that, along with decreased levels of the glycosaminoglycan, alterations in the
type of heparan sulfate were present in diabetic GBM. It was shown that heparan sulfate
isolated from GBM of streptozotocin diabetic rats contained a reduced sulfation state
resulting in an overall loss of effective charge [164,165].
Immunohistochemical studies of heparan sulfate proteoglycan revealed significant
decreases in GBM staining during the early and moderate stages of human diabetes that
persisted throughout the latter severe stages of the disease [105,166]. Quantitation of
heparan sulfate proteoglycan in the GBM of diabetic kidneys taken at autopsy revealed a
70% reduction in this proteoglycan, 1.9 Jlg/mg compared to control, 6.4 Jlg/mg GBM
[12].

lbe effects of high glucose concentration on beparan sulfate proteoglycan synthesis
in mesangial cells have been examined [167]. Cultured mesangial cells were grown 48
hours in high glucose concentrations and the beparan sulfate proteoglycan content was
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reduced by 53% as compared to control cells. The

physiologica~

relevance of this

decreased synthesis of heparan sulfate proteoglycan by mesangial cells is difficult to
interpret as these cells make only 15 % of the total heparan sulfate proteoglycan present
in the glomerulus [47]. In an acute study with spontaneously diabetic KKAy mice,
Ledbetter et al [101] measured the mRNA levels of heparan sulfate proteoglycan in the
cortices at 1, 2, 4 and 6 months of diabetes. No differences in mRNA levels were
detected; however, these results can not be extrapolated to the cells of the glomerulus
because of the contaminating mRNA from other cells of the cortex.
The results thus far demonstrate that the contents of total glycosaminoglycans,
heparan sulfate chains and heparan sulfate proteoglycans are all diminished in the early
stages of experimental and human diabetes. Additionally, perturbations in the processing
of heparan sulfate chains resulting in decreased sulfation were observed in diabetes.
Thus, these studies provide evidence to support a strong relationship between proteinuria
and reduced anionic charge content imparted by heparan sulfate proteoglycan.
In the acute assessment of GBM anionic charge content described in chapter four, a
significant reduction in negative charge content coincided with proteinuria in the diabetic
rats. The alcian blue staining is only an indirect measurement of loss of heparan sulfate
proteoglycan in the diabetic GBM. Other investigations have revealed similar reductions
in anionic charge content in diabetic GBM using cationic probes. Examination of the
diabetic rat and human GBM at the electron microscope level revealed marked loss of
ruthenium red staining [168-170]. It would be interesting if the anionic sites of GBM
were decreased locally in diabetes. In the electron microscopy studies of control GBM,
staining with the cationic probes was localized to the lamina rarae. However, staining in
diabetic GBM was attenuated with patches of no staining in the lamina rarae [168]. Thus,
these results suggest that a marginal loss of anionic charge content could result in altered
penneability. See figures VI. 1 and VL2 for possible models of GBM during nonna! and
diabetic conditions.
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In summary, the thickening of the glomerular basement membrane and the
increased accumulation of mesangial matrix is a consequence of the metabolic
abnormalities in diabetes and reflects a disturbance in the state of function. Presumably,
the biochemical nature of the glomerular ftIter is not maintained. Alterations could occur,
at the genome level involving changes in mRNA levels, at the posttranslational level
involving perturbations in glycosylation, sulfation or hydroxylation steps that could alter
function or assembly of components in the GBM, or at the turnover level involving
changes in enzymes that degrade GBM. The increased blood glucose levels encountered
in diabetes must in some way lead to changes in renal function. Evidence suggests that
glucose has a direct effect to promote collagen biosynthesis by stimulating collagen gene
expression, thus raising the possibility that the actions of diabetes to produce end stage
renal failure could be in part due to direct effects of glucose on the cells of the glomerulus
synthesizing glomerular matrix.

One likely mediator of these effects could be

nonenzymatic glycation of various GBM proteins that alters their structure and function
and prevents normal degradation of collagen.

160
C
EFFECTS OF EXPERIMENT AL GLOMERULONEPHRITIS ON
GLOMERULAR BASEMENT MEMBRANE COMPOSITION.

Human membranous glomerulonephritis is characterized by severe proteinuria
[171]. Early stages of the disease display heavy proteinuria, subepithelial immune
deposits and effacement and fusion of the glomerular epithelial cells. Later stages
display expansion and remodeling of the glomerular

baseme~t

membrane. These

morphological changes are accompanied by persistent and severe proteinuria.
Passive Heymann nephritis (pHN) is an animal model that closely resembles human
membranous glomerulonephritis [13]. PHN is immunologically induced by administration of a single injection of anti-Fx1A antibody. This antibody, generated in sheep, is
directed against rat tubular brush border and cross-reacts with an antigen on the surface
of glomerular epithelial cells [79]. As a result, anti-FxlA antibodies bind to an intrinsic
glomerular epithelial cell antigen and formation of subepithelial immune deposits occurs
[13]. These immune deposits activate the complement system leading to proteinuria five
days after injection of antibody. Proteinuria is followed by structural alteration and
thickening of the GBM around the subepithelial immune deposits. It has been suggested
that alterations of the macromolecular composition of the GBM might change its size- or
charge-selective properties, thus playing a role in progressive proteinuria [172].
Immunohistochemical studies on biopsy tissue of patients with membranous
glomerulonephritis have characterized the distribution of classical and novel chains of
type IV collagen, laminin B2 chain, fibronectin, and entactin/nidogen in the GBM [83].
No differences in staining for the components were observed at stage I of the disease in
which small immune complexes were detected without morphological changes to the
GBM. By stage II, immune deposits had increased in size and first signs of GBM
invaginating (spikes) these deposits were apparent, and an alteration in immunostaining
was detected. The subepithelial spikes or projections and areas of thickened GBM
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demonstrated significant staining for the novel chains [a3(IV) & a4(IV)] of type IV
collagen~

laminin B2 chain and

entactin/nidogen~

but no changes in the staining of

classical chains [al(IV) & a2(N)] of type IV collagen or fibronectin. In stage m, the
immune deposits were completely embedded in the GBM, which displayed marked
thickening. Staining of the aforementioned components continued to increase with an
increase in staining for the classical collagen chains and fibronectin now demonstrable.
In summary, after deposition of immune deposits in the subepithelial side of the GBM,
this membrane sent projections up and around the deposits. These projections consisted
predominantly of novel chains of type IV collagen, laminin and entactin/nidogen that
eventually enveloped the immune deposits. This resulted in a thickened subepithelial
GBM at which time a subsequent increase in classical chains of type IV collagen and
fibronectin in the subendothelial side were detected. Ultimately, this process resulted in
an overall thickened GBM. The immunostaining studies demonstrated alterations in the
GBM macromolecular composition in PHN. However, these alterations might only
reflect

s~ctural

rearrangements of the GBM as the subepithelial immune deposits grow

and not actual alterations in the synthesis of the macromolecules.
. Results from immunohistochemical studies are limited to information on relative
amounts and distributions of components in GBM. These studies can not yield data on
the synthesis and/or absolute amounts of components in the GBM. In an acute study of
PHN, the synthetic rates of type IV collagen, laminin and fibronectin were assessed [80].
The mRNA levels of these macromolecules were quantitated. in isolated glomeruli and
found not to be different from control values at one week, three weeks, or three months
even in the presence of thickened GBM.
Studies of quantitation of type IV collagen, laminin, fibronectin and
entactin/nidogen in GBM from rats with PHN are scarce. The results outlined in chapter
four demonstrated severe proteinuria at day five with no measurable changes in type IV
collagen,

laminin~

fibronectin, and entactin content in the GBM of PHN rats for any time
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point in the study.

Similarly, Floege et al [109] revealed no. changes in these

macromolecules.. It was shown that rats displayed marked proteinuria by day five, with
no significant alterations in glomerular morphology or OBM expansion seen during the
fifteen day period. Immunostaining of renal biopsy for type IV collagen, laminin, slaminin, fibronectin and entactin were unchanged at all time points compared to controls.
At days ten and fIfteen, there was a minor decrease in immunostaining for heparan sulfate
proteoglycan in PHN OBM compared to control. Gene expressions .of type IV collagen,
laminin B2 chain, and s-laminin were examined and the mRNA levels for these
components were unchanged during the fifteen day study.
The study by Floege et al [109] also examined the macromolecular composition and
gene expression of the GBM components during the acute stages of active Heymann
nephritis.

This model of human membranous glomerulonephritis is induced by

immunizing rats with the FxlA antigen . As compared to the passive form, the active
fonn of Heymann nephritis has a slower induction with significant proteinuria occurring
by three months. Thus, the time frames for acute studies in these two fonus of Heymann

nephritis are very

differen~

several weeks versus several months. In contrast to their

results on PHN GBM, rats with active Heymann nephritis showed increased
immunostaining for laminin, s-laminin, fi bronec tin, entactin and heparan sulfate
proteoglycan at three months onward.. The mRNA levels for laminin 82 chain and Slaminin were significantly increased by three months. It was concluded that proteinuria
occurred before the increased synthesis of GBM macromolecules. Thus, the mechanisms
that lead to thickened OBM are probably different from the complement-induced
proteinuria.
Alterations in the charge selective barrier have been suggested as the cause of
proteinuria in membranous glomerulonephritis [84]. Groggel et al used an experimental
model of membranous glomerulonephritis in rabbits and found loss of charge selectivity
in the GBM resulting in proteinuria [84].

Although the total amount of
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glycosaminoglycans was unaltered, the sulfate incorporation into heparan sulfate was
decreased. Thus, the loss of charge selectivity correlated with a change in the structure of
heparan sulfate after twenty-four hours. The importance of an anionic barrier for the
inhibition of protein leakage from the glomerulus was also demonstrated using a
monoclonal antibody against a GBM heparan sulfate proteoglycan [147]. Injection of
this monoclonal antibody resulted in a dose-dependent, transient, and selective
proteinuria that was maximal immediately after injection. Thus, the importance of
maintaining the charge barrier for nonnal filtration is abundantly clear. However, the
relevance of these studies to the induction of proteinuria in membranous
glomerulonephritis is unclear as these studies probably do not involve the complement
cascade.
Recent studies on the intrinsic glomerular epithelial cell antigen with which the
FxlA antibody cross reacts revealed the involvement of integrin receptors. The ability
for a cell to interact with the basement membrane or neighboring cells requires the use of
cell surface receptors. Although specific cell surface receptors for collagens, laminin,
and heparan sulfate proteoglycans have been identified, the best described receptors are
of the integrin family, which are transmembrane proteins that integrate the cytoskeleton
with the basement membrane [110]. Integrins are heterodimeric molecules, consisting of
noncovalently associated a and 13 subunits. Both subunits are transmembrane proteins,
consisting of large amino;..tenninal extracellular domains, single hydrophobic membranespanning sequences, and short carboxy-tenninal cytoplasmic domains [42]. Adler and
Chen [79] demonstrated that the FxlA antibody recognizes the· a3Pl integrin,
specifically the

131 subunit.

In studies with cultured rat glomerular epithelial cells, anti-

FxlA antibody inhibited growth, spreading, and adhesion to type IV collagen, laminin
and fibronectin. Similar results were produced when using anti-PI antibody.
It has been postulated that antibodies to glomerular epithelial cell antigens
interfered with the normal cell-GBM interaction resulting in epithelial cell effacement
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and retraction from the GBM [110].

Subsequent1y~

the altered interaction of the epithelial

cell and GBM in conjunction with the complement system resulted in proteinuria.
In summary, the pathogenesis of PHN, in which severe proteinuria and progressive

thickening of the GBM are characteristic, is unknown. Overt proteinuria occurred
without alterations in type IV collagen, laminin, fibronectin, entactin and anionic charge
content. The lack of change in the GBM macromolecular composition suggested that
these components were not involved in the pathogenesis of proteinuria in PHN. The
mechanism of proteinuria remains elusive. However, recent evidence suggests that the
interference of DOnnal glomerular epithelial cell attachment with the GBM is involved in
the pathogenesis of proteinuria. See figure VI.3 for a possible model of GBM during
PHN conditions.
In conclusion, basement membrane heterogeneity was examined aDd results
presented here demonstrate that mouse glomerular and tubular basement membrane share
similar compositions but differ with respect to specific amounts of some components.
Similarly, macromolecular compositional heterogeneity was shown between animal
species: Mouse and rat OBM share similar components but differ significantly in
amounts. It is currently unknown which individual components impart permeability
properties to the GBM; however, heparan sulfate proteoglycan has been shown to be
involved in generating a charge barrier and thus, restricting the passage of negatively
charged macromolecules. Perhaps laminin, with its high sialic acid content and entactin,
with its sialic acid and sulfate groups, are involved in charge pennselectivity due to these
negatively charged groups on each of these glycoproteins. If the absolute amount of
individual components imparts the functional differences observed between various
basement membranes, then it will be necessary to know the relative amounts of the
macromolecules to determine the functional significance of individual components.
Systems need to be designed that will enable measurements of the penneability properties
of individual components.

For example:

sequential addition of individual GBM
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components onto a support with protein permeability measurements made between
additions. Clearly, much work is needed to understand the physiological relevance, if
any, of each basement membrane macromolecule.
The importance of understanding the GBM composition under normal conditions
cannot be emphasized enough as alterations in composition have been demonstrated to be
involved in various kidney diseases. The common denominators among various diseases
afflicting the kidney are thickened GBM and proteinuria. The present study examined
the macromolecular composition during the acute stages of experimental diabetes and
PHN with emphasis on when compositional changes occurred, if any, in reference to the
onset of proteinuria. It was shown conclusively that these two models of kidney disease
are quite different.

Diabetes affected the GBM macromolecular composition: a

significant reduction in anionic charge content correlated with significant proteinuria and
massive increases in both laminin and fibronectin that occurred in the period immediately
following proteinuria. Therefore, it is likely that the decreased negative charge content
resulted in proteinuria while the explosive increase in laminin and fibronectin were a
compensatory result to ttpatch" the damaged glomerular barrier.

Although overt

proteinuria was evident after five days, passive Heymann nephritis had no effect on the
GBM macromolecular composition:

no changes in type IV collagen, laminin,

fibronectin, entactin or anionic charge content were detected. Thus, the stimuli that lead
to changes in GBM composition in diabetes are likely related to those which result in
proteinuria; however, there appears to be no relationship between the GBM composition
and overt proteinuria in PHN, or between the mechanisms for the induction of proteinuria
in diabetes and PHN.
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Figure VI. 1 A possible model for the macromolecular architecture of
glomerular basement membrane constructed with the known molecules
listed below. A type IV collagen lattice fonns the underlying structural
support to which laminin, fibronectin, entactin/nidogen and heparan sulfate

molecules attach. The GBM is attached and anchored to the opposing
endothelial and epithelial cells through cell surface receptors (for example,
integrins). It is possible that this anchorage provides the necessary shape that
defines, in part, the penneability properties of the GBM. Under nonnal
conditions, the GBM serves to retard the passage of serum proteins from

leaving the capillary lumen yielding an ultrafutrate in the urinary space.
Macromolecules are drawn to scale with respect to each other.

type N collagen

Laminin

•

t

Fibronectin

:::=-

Entactin/Nidogen .....
Heparan sulfate proteoglycan (HMW)

."Illl~

Heparan sulfate proteoglycan (LMW)

X

Integrin receptor

Serum proteins

Urinary space

eee

• •

•

e

•

Capillary lumen e

Figure VI.1

200nm

168

Figure VI.2 Proposed model of GBM during diabetic conditions. Diabetes is
characterized by alterations in GBM and proteinuria. A decrease in anionic
charge content is intimately associated with the appearance of proteinuria. The
model shown here depicts a net loss of charge as a result of diminished amounts
of heparan sulfate proteoglycan. Loss of negative charge may result in pathways
opening up for plasma proteins to now traverse. The functional significance of
increases in laminin and fibronectin is less clear. However, increased amount of
these molecules may interfere with normal deposition and assembly of the GBM
structure. Additionally, the hyperglycemia encountered results in nonenzymatic
glycation of macromolecules. Interference and alterations in nonnal cross linking
and packing of components might result in significant alterations in overall
structure, therefore yielding a "leaky" glomerular basement membrane.
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Figure VI.3

Proposed model of GBM during passive Heymann nephritis

conditions.. Passive Heymann nephritis results in rapidly induced and severe
proteinuria despite no alterations in GBM composition. The appearances of
subepithelial immune deposits are undoubtedly a result of antibodies binding to an
intrinsic cell surface antigen on glomerular epithelial cells. This antigen was
recently discovered to be an integrin receptor. This receptor binds to type IV
collagen, laminin, and fibronectinthus, anchoring the GBM to the epithelial and
endothelial cells of the glomerulus. Thus, in this model of human membranous
glomerulonephritis, antibodies interfere with the anchoring of the GBM to the
epithelial cells. This loss of anchorage results in fusion and effacement of
epithelial cells and in conjunction with distortion of GBM by the enlarging
subepithelial immune deposits causes structural alterations in the glomerular
filtration barrier that ultimately lead to proteinuria.
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